ArticlePDF AvailableLiterature Review

Abstract and Figures

Candida albicans is a polymorphic fungus that has the ability to rapidly switch between yeast and filamentous forms. The morphological transition appears to be a critical virulence factor of this fungus. Recent studies have elucidated the signal transduction pathways and quorum sensing molecules that affect the morphological transition of C. albicans. The metabolic mechanisms that recognize, and respond to, such signaling molecules and promote the morphological changes at a system level, however, remain unknown. Here we review the metabolic basis of C. albicans morphogenesis and we discuss the role of primary metabolic pathways and quorum sensing molecules in the morphogenetic process. We have reconstructed, in silico, the central carbon metabolism and sterol biosynthesis of C. albicans based on its genome sequence, highlighting the metabolic pathways associated with the dimorphic transition and virulence as well as pathways involved in the biosynthesis of important quorum sensing molecules.
Content may be subject to copyright.
Review
The metabolic basis of Candida albicans morphogenesis and quorum sensing
Ting-Li Han
a
, Richard D. Cannon
b
, Silas G. Villas-Bôas
a,
a
Centre for Microbial Innovation, School of Biological Sciences, The University of Auckland, 3sA Symonds Street, Auckland 1142, New Zealand
b
Department of Oral Sciences, The University of Otago, Dunedin, New Zealand
article info
Article history:
Received 23 July 2009
Accepted 5 April 2011
Available online 12 April 2011
Keywords:
Candida albicans
Filamentous growth
Central carbon metabolism
Amino acid biosynthesis
Sterol biosynthesis
Farnesol
Fungi
Dimorphism
Amino acids
Biosynthesis
Systems biology
Functional genomics
Transcriptomics
Proteomics
Metabolomics
abstract
Candida albicans is a polymorphic fungus that has the ability to rapidly switch between yeast and fila-
mentous forms. The morphological transition appears to be a critical virulence factor of this fungus.
Recent studies have elucidated the signal transduction pathways and quorum sensing molecules that
affect the morphological transition of C. albicans. The metabolic mechanisms that recognize, and respond
to, such signaling molecules and promote the morphological changes at a system level, however, remain
unknown. Here we review the metabolic basis of C. albicans morphogenesis and we discuss the role of
primary metabolic pathways and quorum sensing molecules in the morphogenetic process. We have
reconstructed, in silico, the central carbon metabolism and sterol biosynthesis of C. albicans based on
its genome sequence, highlighting the metabolic pathways associated with the dimorphic transition
and virulence as well as pathways involved in the biosynthesis of important quorum sensing molecules.
Ó2011 Elsevier Inc. All rights reserved.
Contents
1. Introduction . . . ...................................................................................................... 748
2. Signaling pathways and transcriptional regulators associated with C. albicans morphogenesis . . . . . . . . . . ............................. 749
3. Quorum sensing molecules and C. albicans morphogenesis . . . ................................................................ 752
4. In silico reconstruction of the central carbon metabolism of C. albicans and the biosynthesis of quorum sensing molecules . . . . . .......... 754
4.1. Glycolysis. . . . . . . . . . . . . ............................. ............................................................ 754
4.2. Pentose phosphate pathway . . . . . . . . . . . . . . .......... ............................................................... 754
4.3. Pyruvate dehydrogenase. ............................. ............................................................ 754
4.4. TCA cycle . . . . . . . . . . . . . ............................................. ............................................ 754
4.5. Glyoxylate shunt . . . . . . . ................................................................... ...................... 754
4.6. Amino acid biosynthesis . ............................................. ............................................ 756
4.6.1. Glutamate biosynthesis . . . . . .............................................................................. 756
4.6.2. Aromatic amino acid and quorum sensing molecule biosynthesis . . . . . . . . . ........................................ 756
4.6.3. Regulation of global amino acid biosynthesis. . . . . . . ........................................................... 756
5. Central carbon metabolism, virulence, and morphogenesis of C. albicans ........................................................ 756
6. The effect of metabolic genes on the utilization of carbon sources . . . . . . . . . . . . . . . . ............................................. 757
7. In silico reconstruction of the sterol biosynthetic pathway and farnesol biosynthesis in C. albicans ................................... 757
8. The integration of quorum sensing and central carbon metabolism in C. albicans ................................................. 757
9. Final remarks . . ...................................................................................................... 758
References . . . . ...................................................................................................... 759
1087-1845/$ - see front matter Ó2011 Elsevier Inc. All rights reserved.
doi:10.1016/j.fgb.2011.04.002
Corresponding author. Fax: +64 9 373 7416.
E-mail addresses: richard.cannon@otago.ac.nz (R.D. Cannon), s.villas-boas@auckland.ac.nz (S.G. Villas-Bôas).
Fungal Genetics and Biology 48 (2011) 747–763
Contents lists available at ScienceDirect
Fungal Genetics and Biology
journal homepage: www.elsevier.com/locate/yfgbi
1. Introduction
Candida albicans is a human commensal fungus that can be iso-
lated from approximately 70% of the healthy population (Mavor
et al., 2005). In the majority of cases C. albicans is harmless, how-
ever, if the person is immunocompromised, it can be an opportu-
nistic pathogen (Wingard et al., 1979). C. albicans is the fourth
leading cause of nosocomial bloodstream infections (Pfaller and
Diekema, 2007), with an attributable mortality of 37–44% in se-
verely immunocompromised patients (Wisplinghoff et al., 2004;
Leroy et al., 2009; Moran et al., 2010).
C. albicans and other polymorphic fungi (e.g. Histoplasma capsu-
latum) have the remarkable ability to grow in several distinct mor-
phological forms: yeast, hyphae, and pseudohyphae, according to
environmental conditions (Bastidas and Heitman, 2009; Sudbery
et al., 2004). The true hyphae and pseudohyphae (chains of ellipti-
cal cells with constrictions at the septa) are often referred to as fil-
amentous forms (Odds, 1988). The ability to switch rapidly from
yeast-to-filamentous growth or vice versa in response to certain
environmental cues is considered to be a critical virulence factor
for these fungi (Lo et al., 1997; Mitchell, 1998; Brown and Gow,
1999; Gow et al., 2002; Rooney and Klein, 2002; Nemecek et al.,
2006). In C. albicans, each morphology is believed to confer discrete
advantages in the course of infection. The yeast form is important
for dissemination through the bloodstream (Bendel et al., 2003; Sa-
ville et al., 2003), and adheres to endothelial surfaces (Grubb et al.,
2009). The filamentous forms, on the other hand, are more adapted
for invasion through the host epithelial tissue (Rooney and Klein,
2002), and also have a higher resistance to phagocytosis due to
their morphology. Indeed, an engulfed C. albicans yeast cell can de-
stroy a macrophage if filamentous growth is triggered after phago-
cytosis (Arai et al., 1977; Lorenz et al., 2004), and filamentous
forms have a higher resistance to neutrophil killing (Smail et al.,
1992; Fradin et al., 2005). Moreover, experimental studies support
the hypothesis that the morphological transition is an essential vir-
ulence factor for C. albicans. For instance, a reduced mortality rate
has been reported in animal infection models for mice inoculated
with C. albicans mutants unable to undergo the yeast-to-filamen-
tous transition (Lo et al., 1997; Gale et al., 1998). In addition, the
induction of hyphal gene expression promoted virulence in a
mouse model of systemic candidiasis (Carlisle et al., 2009).
The morphogenesis of C. albicans is predominately determined
by environmental signaling. The yeast-to-filamentous transition
can be triggered by serum, proline, N-acetylglucosamine, different
carbon sources, and other cues as summarized in Table 1. However,
there is a lack of understanding about how C. albicans regulates its
morphogenesis in response to these environmental changes. In
addition, the synchronised morphogenesis of C. albicans cells, and
other dimorphic fungi, seems to be coordinated within the cell
population by chemical signals (Chen and Fink, 2006; Hogan,
2006a,b; Nickerson et al., 2006;Chen et al., 2007). Dimorphic fungi
are known to produce several signaling metabolites. Farnesol,
which suppresses filamentous formation in C. albicans, is the best
characterized of these molecules (Hornby et al., 2001), but the
mechanism by which farnesol is sensed by C. albicans is not yet
clear. Tyrosol is another signaling molecule produced by C. albicans
and it stimulates the yeast-to-hypha conversion (Chen et al., 2004).
Other metabolites such as estradiol (mammalian metabolite) and
Table 1
The effect of environmental cues on the morphogenesis of C. albicans.
Environmental cues Effect on morphogenesis References
25 °C or lower "Yeast formation Lee and Mitchell (1979)
37 °C or higher "Pseudohypha formation (maintains the yeast form at pH
4.5)
Lee and Mitchell (1979) and Lee et al. (1999)
5–15% CO2 "Predominantely pseudohypha formation Bahn and Mühlschlegel (2006), Klengel et al. (2005), Mock et al.
(1990) and Sims (1986)
"Hypha formation Brown et al. (1999)
Ca
2+
;Hypha formation (absence of other divalent ions) Holmes et al. (1991) and Sabie and Gadd (1989)
"Hypha formation (in presence of Mg
2+
)
D
-glucose "Hypha formation (at 37 °C and pH 7–8) Hrmova and Drobnica (1981), Hudson et al. (2004) and Vidotto et al.
(1996a)
0.2% of glucose, galactose,
fructose or sucrose
"Hypha formation Maidan et al. (2005b)
Fructose "Hypha formation (in the absence of nitrogen source) Vidotto et al. (1996b)
Lee’s medium "Hypha formation (at 37 °C) Lee et al. (1975)
;Hypha formation (at 25 °C)
Lithium ;Hypha formation (except in liquid culture and requires
at least 15 mM LiCl)
Martins et al. (2008)
Low ammonia medium "Hypha formation (at pH 6.7) Eisman et al. (2006) and Holmes and Shepherd (1987)
N-acetylglucosamine "Hypha formation (inhibited when pH < 4.5) Holmes and Shepherd (1987) and Sullivan and Shepherd (1982)
pH 4.5 (acid pH) "Yeast formation (in the presence of glucose) Lee and Mitchell (1979) and Pollack and Hashimoto (1987)
pH 6–8 "Pseudohypha formation (but maintains the yeast form
at 25 °C)
Lee and Mitchell (1979) and Pollack and Hashimoto (1987)
Proline "Hypha formation (not observed when pH < 5.0) Dabrowa et al. (1976) and Holmes and Shepherd (1987)
Serum "Hypha formation Hilmioglu et al. (2007) and Reynolds and Braude (1956)
Spider medium "Hypha formation Liu et al. (1994) and Toenjes et al. (2005)
3-oxo-C12-homoserine lactone ;Hypha formation Hogan et al. (2004)
;Pseudohypha formation
Dodecanol ;Hypha formation Hogan et al. (2004)
;Pseudohypha formation
Human blood without white
blood cell
"Hypha formation Fradin et al. (2005)
Phagocytosis or surrounded by
neutrophils
;Hypha formation Barelle et al. (2006), Fradin et al. (2005) and Rubin-Bejerano et al.
(2003)
Phagocytosis by macrophages "Hypha formation Barelle et al. (2006), Fradin et al. (2005), Lorenz et al. (2004) and
Rubin-Bejerano et al. (2003)
Parenteral lipid emulsion "Germ tube formation Swindell et al. (2009)
Note:": inducing, ;: suppressing
748 T.-L. Han et al. / Fungal Genetics and Biology 48 (2011) 747–763
dibutyryl cAMP are also known to affect C. albicans morphogenesis
(Niimi et al., 1980; White and Larsen, 1997; Cheng et al., 2006). De-
spite many studies showing the effect of small molecules on fungal
morphogenesis, the pathways that recognize such signals and their
effect on virulence are poorly characterized. Thus, this article re-
views our current knowledge of C. albicans morphogenesis from a
metabolic point of view and relates it to the activity of central car-
bon metabolism and the biosynthesis of quorum sensing
molecules.
2. Signaling pathways and transcriptional regulators associated
with C. albicans morphogenesis
In the last 10 years, the use of gene knockout mutagenesis and
transcriptional studies have revealed signaling pathways, tran-
scriptional factors, as well as other regulatory components that
collectively drive the yeast-to-hyphal transition, or its reversion
(Gow, 2009). The roles of signaling pathways and transcriptional
regulators on C. albicans morphogenesis have been discussed in
many review articles (Alonso-Monge et al., 2009b; Bahn et al.,
2007; Biswas et al., 2007; Brown and Gow, 1999; Dhillon et al.,
2003; Enrst, 2000; Hogan and Sundstrom, 2009; Lengeler et al.,
2000; Liu, 2001, 2002; Navarro-García et al., 2001; Román et al.,
2007; Wang, 2009). An important class of proteins involved early
in signaling pathways is the GTPase superfamily. These G-proteins
bind and hydrolyse guanosine triphosphate (GTP) in response to
certain environmental stimuli (e.g. glucose, proline, pH, nitrogen
deficiency, serum, and oxidative stress), and regulate downstream
signal transduction. In C. albicans, the GTPases that regulate mor-
phogenesis include G-protein-coupled receptor Gpr1p (Maidan
et al., 2005), and the following members of the Ras superfamily:
Rho-type Cdc42p (Johnson, 1999); RHeb-type Rhb1p (Tsao et al.,
2009); and a small GTPase, Ras1p (Feng et al., 1999; Leberer
et al., 2001).
GTPases are thought to be the main regulators that activate the
two best-studied signaling pathways involved in C. albicans
morphogenesis: the cAMP-Protein Kinase A (PKA), and the
Mitogen-Activated Protein Kinase (MAPK), pathways (Fig. 1). The cAMP-
PKA pathway involves adenylyl cyclase (Cdc35p) (Rocha et al.,
Fig. 1. Signal transduction pathways and transcriptional regulators that affect the filamentous growth of C. albicans and the effect of farnesol on some of these pathways. In
response to filamentous-inducing conditions, GTPases (Gpa2p, Ras1p, and Cdc42p) activate two well-characterized signaling pathways; the Cek1p mediated MAP kinase
pathway and cAMP-PKA pathway. These lead to the activation of transcriptional regulators Cph1p and Efg1p, respectively, which promote filamentous growth. Nitrogen
starvation activates both the MAP Kinase and cAMP-PKA pathways via ammonium permease (Mep2p). Adenylyl cyclase (Cdc35p) not only responds to Ras1p, it is also
activated in response to G-proteins (Gpr1p and Gpa2p), which are activated by glucose deficiency and the presence of methionine. Cdc35p also acts as a sensor for CO
2
and
peptidoglycans. Oxidative stress and osmotic stress are sensed by a two component system (Sln1p and Ssk1p), which in turn suppresses Hog1p MAP kinase pathways. At
37 °C, Pi4p5kp synthesizes phosphatidylinositol 4,5-bisphosphate (PIP
2
) to promote the release of intracellular Ca
2+
. The role of other individual genes are summarized in
Table 2. Quorum sensing molecule farnesol inhibits filamentous growth by suppressing the expression of RAS1, SHO1 HST7, CEK1, PDE2, and HWP1, while it upregulates
filamentous-suppressing genes such as TUP1 and HOG1. Blue boxes represent the membrane-anchored proteins, red boxes represent the transcriptional regulators, and the
purple box indicates DNA-binding proteins (Nrg1p, Mig1p, or Rfg1p). (For interpretation of the references to colour in this figure legend, the reader is referred to the web
version of this article.)
T.-L. Han et al. / Fungal Genetics and Biology 48 (2011) 747–763 749
Table 2
Genes involved in the morphogenesis of C. albicans.
Genes Gene functions Involvement in morphogenesis References
Signaling pathway genes
BCY1 The regulatory subunit of PKA "Hypha formation Cassola et al. (2004)
CAP1 Adenylate cyclase-associated protein "Hypha formation Bahn and Sundstrom (2001)
CDC42 Rho-type GTPase; a main regulator of cell polarity in fungi
with two forms; CDC42-GTP and CDC42-GDP. CDC42-GTP
activates CST20 and promotes septin ring formation
Only CDC42-GTP: "hypha formation Bassilana et al. (2003), Su et al. (2005) and
Court and Sudbery (2007)
CDC24 The GDP-GTP exchange factor for CDC42; promotes CDC42-
GTP formation
"Hypha formation Bassilana et al. (2003)
RGA2, BEM3 CDC42 GTPase-activating proteins; promotes CDC42-GDP
formation
;Hypha formation Court and Sudbery (2007) and Wang
(2009)
CDC35 or
CYR1
Adenylyl cyclase, a sensor that responds to CO
2
and bacterial
peptidoglycan (PGN)-like molecules
"Hypha formation Rocha et al. (2001) and Klengel et al.
(2005)
"Pseudohypha formation Xu et al. (2008)
CDC53 Encodes cullin, part of ubiquitin-ligase complex SCF ;hypha formation Trunk et al. (2009)
CST20 MAPKK kinase of CEK1 pathway "Hypha formation Leberer et al. (1996)
HST7
a
MAPK kinase of CEK1 pathway "Hypha formation Leberer et al. (1996)
CEK1
a
MAP kinase of CEK1 pathway; phosphorlyation is prevented
by farnesol
"Hypha formation Csank et al. (1998) and Román et al.
(2009)
CPP1 Cek1p phosphatase, Inactivates the Cek1p ;Hypha formation Csank et al. (1997)
CRK1
a
Cdc2-related kinase, suppressed by farnesol "Hypha formation Chen et al. (2000) and Sato et al. (2004)
GPA2 A G-protein
a
subunit "Hypha formation Sa
´nchez-Marti
´nez and Pe
´rez-Marti
´n
(2002) and Maidan et al. (2005)
MKC1 MAPK kinase; maintains cell wall integrity "Hypha formation Navarro-García et al. (1998)
YPD1 A phosphohistidine intermediate protein that transfers a
phosphate from Sln1p to Ssk1p
Expressed in both yeast and hyphal forms Payne et al. (2000)
SSK1 Response regulator of two component system; suppresses
HOG1-mediated MAPK pathways and it is associated with cell
wall synthesis and oxidative-stress response
"Hypha formation Calera et al. (2000) and Menon et al.
(2006)
SSK2 MAPKK Kinase of HOG1 pathway ;Hypha formation Cheetham et al. (2007)
PBS2 MAPK Kinase of HOG1 pathway, essential for oxidative-stress
response
;Hypha formation Arana et al. (2005)
HOG1
a
High osmolarity glycerol MAP kinase; responds to osmotic
stress, temperature upshift, oxidative stress. Represses the
activity of CEK1, regulates respiratory metabolism, and
upregulated by farnesol
;Hypha formation José et al. (1996) and Eisman et al. (2006)
Alonso-Monge et al. (2003), Smith et al.
(2004) and Alonso-Monge et al. (2009a)
PDE2
a
Phosphodiesterase, suppressed by farnesol "Hypha formation Bahn et al. (2003) and Sato et al. (2004)
"Pseudohypha formation Smith et al. (2004)
PI4P5 K phosphatidylinositol-4 phosphate 5-kinase; synthesizes
phosphatidylinositol 4,5-bisphosphate (PIP2) in response to
high temperature
"Hypha formation Hairfield et al. (2002)
RAD53 The kinase involved in mediating DNA damaged–induced
hyphal growth
"Hypha formation Shi et al. (2007)
RAS1
a
A member of the GTPase superfamily; responds to nitrogen
starvation, glucose and serum. Suppressed by farnesol
"Hypha formation Feng et al. (1999)
CDC25 RAS1 guanine exchange factor; responds to glucose and
induces cAMP signaling pathway
"Hypha formation Enloe et al. (2000)
RHB1 Rheb of Ras superfamily, involves in the nitrogen starvation
inducing filamentous growth
;Hypha formation Tsao et al. (2009)
TSC2 Homolog of human tuberous sclerosis protein 2, negatively
regulates the GTPase activity of RHB1
"hypha formation Tsao et al. (2009)
SHO1 An adaptor protein that responds to oxidative stress and cell
wall biosynthesis, It activates CEK1 Kinase pathway.
"Hypha formation Roma
´n et al. (2005)
TPK1 The catalytic subunit of PKA "Hypha formation Cloutier et al. (2003)
TPK2 The catalytic subunit of PKA "Hypha formation Cloutier et al. (2003)
YAK1 Ser/Thr protein kinase; Upstream of Tup1p "Hypha formation Goyard et al. (2008)
Transcription factor genes
CPH1 Transcription factor that is activated by MAPK pathway;
responds to starvation and
"Hypha formation Lo et al. (1997)
GlcNAc "Pseudohypha formation
CZF1 Putative zinc finger transcription factor; responds to agar-
embedded growth conditions
"Hypha formation Brown et al. (1999)
EFG1 Transcription factor that is activated by PKA pathway;
responds to serum, upregulates glycolysis and downregulates
TCA cycle
"Hypha formation Stoldt et al. (1997) and Leng et al. (2001)
"Pseudohypha formation
TEC1 A transcription factor - member of the TEA/ATTS family;
regulated by EFG1
"Hypha formation Schweizer et al. (2000) and Lane et al.
(2001)
TUP1
a
A general transcriptional repressor; regulates glycolysis and
TCA cycle. Upregulated by farnesol
;Hypha formation Braun and Johnson (1997), Cao et al.
(2005) and Kebaara et al. (2008)
SSN6 A general transcriptional repressor forms a complex with
TUP1
;Pseudohypha formation Hwang et al. (2003)
MIG1 DNA-binding protein (DBP) binds to TUP1 ;Hypha formation Murad et al. (2001)
NRG1 DBP binds to TUP1 ;Hypha formation Braun et al. (2001) and Murad et al. (2001)
;Pseudohypha formation
750 T.-L. Han et al. / Fungal Genetics and Biology 48 (2011) 747–763
Table 2 (continued)
Genes Gene functions Involvement in morphogenesis References
RFG1 Repressor for filamentous growth; DBP binds to TUP1 ;Hypha formation Kadosh and Johnson (2001) and Khalaf
and Zitomer (2001)
;Pseudohypha formation
RIM101 pH-response regulator, activated by alkaline conditions and
regulates both PHR1 and PHR2. It is required for ARO9 pH
dependent expression and required for virulence during
systemic infection
"Hypha formation Ramon et al. (1999) and Nobile et al.
(2008)
RGT1 A transcriptional repressor for genes that encode hexose
transporters, N-acetylglucosamine transporter (NGT1), and
downregulates glycolysis
;Hypha formation Sexton et al. (2007)
GCN4 General amino acid control; regulates both morphogenesis
and metabolic responses to amino acid starvation
"Hypha formation Tripathi et al. (2002)
"Pseudohypha formation
UME6 A transcriptional regulator; encodes zinc finger DNA-binding
protein
"Hypha formation Strich et al. (1994) and Banerjee et al.
(2008)
"Pseudohypha formation
Receptor genes
CDR1, CDR2 Multidrug transporters of the ABC family: an efflux pump
that removes estradiol from the cell
"Germ tube is formed in the present of
estradiol
Cheng et al. (2006)
GAP1 General amino acid permease; the expression of transporter
is induced by GlcNAc and Cph1p.
"Hypha formation Biswas et al. (2003)
HGT4 Glucose and galactose sensor "Hypha formation Brown et al. (2006) and Brown et al.
(2009)
GPR1 G-protein-coupled receptor; upstream of cAMP-PKA
pathway, senses methionine and proline
"Hypha formation Maidan et al. (2005) and Maidan et al.
(2005)
HGT4 Glucose sensor; induces the expression of hexose
transporters (e.g. HGT12,HXT12 and HGT7)
;Hypha formation Brown et al. (2006)
;Pseudohypha formation
CHK1
a
/NIK1/
SLN1
Histidine kinase of two component system; SLN1 is the
upstream components of Hog1-mediated MAPK pathway.
The CHK1 mutant overcomes the hyphal-suppressing effect
of farnesol
"Hypha formation Nagahashi et al. (1998) and Calera and
Calderone (1999), Yamada-Okabe et al.
(1999) and Kruppa et al. (2004)
NGT1 N-acetylglucosamine transporter In a homozygous NGT1 deletant, hyphal
growth cannot be induced by GlcNAc
Alvarez and Konopka (2007)
MEP2 Ammonium permease; senses nitrogen starvation.
Expression is suppressed by: 10 mM of NH
4+
, overexpression
of RHB1, and TSC2 deletion. It activates both MAP kinase
pathway and cAMP-PKA pathway
"Pseudohypha formation Biswas and Morschhäuser (2005) and Tsao
et al. (2009)
Metabolic genes
ALO1
D
-arabinono-1,4-lactone oxidase; catalyzies the last step of
D-erythroascorbic acid biosynthesis
"Hypha formation Huh et al. (2001)
ATC1 Cell wall-linked acid trehalase, converts exogenous galactose
into glucose.
"Hypha formation Pedreño et al. (2007)
"Pseudohypha formation
GAL10 UDP-galactose-4-epimerase; converts galactose into glucose ;Hypha formation Singh et al. (2007)
PDX1 Pyruvate dehydrogenase "Hypha formation Vellucci et al. (2007)
"Pseudohypha formation
TSP1 Trehalose-6-phosphate synthase; involved in trehalose
biosynthesis.
"Hypha formation Zaragoza et al. (1998)
Cell wall genes
ALS1 Adhesin; hypha specific gene "Hypha formation Fu et al. (2002)
"Pseudohypha formation
HWP1
a
Cell wall protein; hyphal-specific gene, involved in cellular
adhesion during biofilm formation, and suppressed by
farnesol
"Hypha formation Sharkey et al. (1999) and Ramage et al.
(2002), Enjalbert and Whiteway (2005)
and Padovan et al. (2009)
INT1 Integrin-like, role in adhesion "Hypha formation Gale et al. (1998) and Asleson et al. (2001)
"Pseudohypha formation
PHR1 GPI-anchored glycosidase; cell wall structure, expressed at
pH 5.5 or alkaline pH
"Hypha formation Ghannoum et al. (1995) and De Bernardis
et al. (1998)
"Pseudohypha formation
PHR2 GPI-anchored glycosidase; cell wall structure, expressed at
acidic pH
"Hypha formation Mühlschlegel and Fonzi (1997) and De
Bernardis et al. (1998)
PMT1 Mannosyltransferase "Hypha formation Timpel et al. (1998)
PMT6 Mannosyltransferase, role in adhesion and antifungal
resistance
"Hypha formation Timpel et al. (2000)
Cell cycle-associated genes
CDC28 Cyclin-dependent kinase; phosphorylates Cdc11 p(septin
gene) in association with either CCN1 or HGC1.CDC28-HGC1
negatively regulates RGA2 and also phosphorylates Efg1p
"Hypha formation Sinha et al. (2007) and Wang et al. (2009)
HGC1 Hyphal-specific G1 cyclin related protein; maintains the
localization of polarity proteins (e.g. actin) on hyphal tip,
regulated by cAMP-PKA pathway and Tup1p
"Hypha formation Zheng and Wang (2004)
CCN1 G
1
cyclin; role in maintaining hyphal growth "Hypha formation Loeb et al. (1999)
(continued on next page)
T.-L. Han et al. / Fungal Genetics and Biology 48 (2011) 747–763 751
2001) and PKA (Bcy1p, Tpk1p and Tpk2p) (Cassola et al., 2004;
Cloutier et al., 2003)(Table 2,Fig. 1). Eventually, the PKA pathway
activates an important transcription factor encoded by EFG1 (Stoldt
et al., 1997) that induces the expression of hyphal-specific genes
(e.g. HWP1,HYR1 and ALS1)(Fu et al., 2002; Leng et al., 2001; Shar-
key et al., 1999). MAPK pathways typically consist of three kinases;
MAPKKK, MAPKK, and MAPK that are sequentially activated one
after the other by phosphorylation. There are several different
MAPK pathways that have been described and linked to the mor-
phological changes of C. albicans (e.g. Cek1p, Hog1p, and Mkc1p
MAPK pathways) (Alonso-Monge et al., 2009b; Cheetham et al.,
2007; Csank et al., 1998; Eisman et al., 2006; Leberer et al., 1996,
2001; Navarro-García et al., 1998). Fig. 1 illustrates how these sig-
naling pathways and regulatory components are interconnected,
and Table 2 summarizes how these components lead to modifica-
tions in cell wall organization, cell polarity, metabolism, cell cycle,
virulence factors, and morphogenesis. Furthermore, transcriptome
studies have identified several hyphal-suppressing genes in C. albi-
cans. These repressor genes, such as TUP1,SSN6,NRG1,MIG1, and
HOG1, are involved in the regulation of central carbon metabolism
(Braun and Johnson, 1997; Hwang et al., 2003; José et al., 1996;
Murad et al., 2001) as illustrated in Table 3. There are many other
genes that are known to be involved in the morphological switch of
C. albicans. The role of those genes and how they may influence, or
have their expression changed during, morphogenesis are briefly
summarized in Table 2.
3. Quorum sensing molecules and C. albicans morphogenesis
The phenomenon of ‘‘quorum sensing’’ is being increasingly rec-
ognized as a fundamental aspect of microbial cell-to-cell commu-
nication and signaling. Fuqua et al. (1994) first coined this term
to describe the cooperative behaviour of bacterial cells that can
only take place when a certain cell population density threshold
is reached. Quorum sensing is often referred to as autoinduction,
a process by which individual cells release small diffusible mole-
cules into their environment and these molecules are sensed by
all cells in the population (Gray et al., 1994; Hense et al., 2007;
Nealson, 1977). When high cell density is reached, these autoin-
ducing molecules accumulate above a certain threshold level, acti-
vating and/or repressing certain genes (Fuqua et al., 1994), which
in turn induce complex cellular behaviour such as secretion of
extracellular enzymes (Rosenberg et al., 1977), bioluminescence
(Eberhard, 1972; Eberhard et al., 1981; Fuqua et al., 1994), plasmid
transfer (Piper et al., 1993), antibiotic biosynthesis (Bainton et al.,
Table 2 (continued)
Genes Gene functions Involvement in morphogenesis References
CLN3 G
1
cyclin; is important for yeast budding and negatively
regulates the yeast-to-hyphal transition
;Hypha formation Bachewich and Whiteway (2005) and Lazo
et al. (2005)
CLB2, CLB4 B-cyclins that are negative regulators of polarized growth ;Hypha formation Bensen et al. (2005)
;Pseudohypha formation
Others genes
CDC10, CDC11 Non-essential septin genes cdc10 and cdc11 mutants show abnormal
hyphal structure
Warenda et al. (2003)
Note:": induction,;: suppression.
Observations are based on knockout mutagenesis studies.
a
The expression of these genes is regulated by farnesol.
Table 3
The effect of morphogenesis-related genes, and farnesol, on Candida albicans metabolism based on DNA array studies or large-scale protein analyses
.
Metabolism of: EFG1 GCN4 HOG1 TUP1 MIG1 NRG1 RIM101 SSN6 NGT1 Farnesol
Alanine
Arginine ""pH8
Asparagine ";pH4
Aspartate
Cysteine
Ergosterol biosynthesis ;;
Glutamate ;";;; "pH8
Glutamine
Glycine "
Glycolysis "" " ;; ;
Glyoxylate shunt ;
Histidine ";;pH4
"pH8
Isoleucine ";pH8
Leucine ";;;
Lysine ";
Methionine "
Pentose phosphate "
Phenylalanine "
Proline "
Serine "
TCA cycle ;";
Threonine "
Tryptophan "
Tyrosine "
Valine "
Note:": gene/farnesol upregulates one or more enzymes in a particular biochemical pathway.
;: gene/farnesol downregulates one or more enzymes in a particular biochemical pathway ;
pH4
: assayed at pH 4, "
pH8
: assayed at pH 8.
752 T.-L. Han et al. / Fungal Genetics and Biology 48 (2011) 747–763
1992), biofilm development (Alem et al., 2006), and morphological
switches (Hornby et al., 2001). Despite quorum sensing being well-
characterized and evolutionarily-conserved between diverse bac-
terial species (Gray and Garey, 2001; Gray et al., 1994), only a
few quorum sensing like-responses have been reported in eukary-
otes, such as H. capsulatum (Kügler et al., 2000), C. albicans (Chen
et al., 2004; Hornby et al., 2001), and Saccharomyces cerevisiae
(Chen and Fink, 2006). Curiously, in each of these studies quorum
sensing was associated with the morphological switch from yeast-
to-filamentous forms, or vice versa.
Eukaryotic quorum sensing is best studied in C. albicans. This
fungus has the greatest number of quorum sensing molecules
(QSMs) identified to date. Tryptophol and phenylethyl alcohol
were the first QSMs identified in C. albicans (Lingappa et al.,
1969). These QSMs are produced by C. albicans and inhibit both cell
growth and germ tube formation - whether the inhibition of germ
tube formation is due to the inhibition of growth remains unclear.
In recent years, three additional QSMs have been isolated from C.
albicans; farnesol, tyrosol and farnesoic acid (Chen et al., 2004;
Hornby et al., 2001; Hornby and Nickerson, 2004; Oh et al.,
2001), although farnesoic acid has only been reported in one C.
albicans strain (ATCC 10231, Oh et al., 2001) and has a lower activ-
ity than farnesol (Hornby and Nickerson, 2004).
Farnesol is the best characterized QSM in C. albicans and it is
known to block the yeast-to-filamentous transition at high cell
density, as well as under other hyphal-inducing conditions (e.g.
serum, proline, and N-acetylglucosamine) (Hornby et al., 2001);
but it is incapable of stopping the elongation of pre-existing hy-
phae (Mosel et al., 2005; Navarathna et al., 2005). Moreover, far-
nesol is continuously released into the environment during
growth, and its accumulation in the medium is roughly propor-
tional to the cell density (Hornby et al., 2001). It has been pro-
posed that farnesol is secreted by the cells to inhibit germ tube
formation in the late stage of biofilm development where there
is a high density of interwoven filamentous cells, and, therefore,
it promotes the dispersal of yeast cells to colonize new environ-
ments (Alem et al., 2006). After farnesol was discovered in C. albi-
cans cultures, several studies have been undertaken to investigate
the mechanisms by which QSMs affect morphogenesis. For in-
stance, Sato et al. (2004) used RT-PCR to show that farnesol inhib-
ited MAP kinase cascades via the suppression of HST7 and CPH1
gene expression (Fig. 1). Hog1p phosphorylation also increased
in the presence of farnesol (Smith et al., 2004). Cao et al. (2005)
demonstrated that several morphogenesis-associated genes were
downregualted (e.g. CRK1 and PDE2) and some upregulated (e.g.
TUP1) by the presence of farnesol. It has been suggested that hy-
phal formation induced by the cAMP-PKA pathway can be re-
pressed by farnesol which suppresses the RAS1-CDC35 pathway
(Davis-Hanna et al., 2008). Kebaara et al. (2008) showed that far-
nesol inhibits hyphal formation by upregulating the global repres-
sor of TUP1 because it failed to suppress hyphal development in
tup1/tup1 and nrg1/nrg1 null-mutants. Recently, Román et al.
(2009) showed that farnesol prevents the activation of Cek1p,
which is a part of the MAPK cascade. In summary, the studies
to date show that farnesol inhibits C. albicans morphogenesis by
suppressing both MAPK and cAMP-PKA pathways and promoting
the expression of hyphal-suppressor genes such as TUP1 and
HOG1 (Fig. 1). How yeast cells sense farnesol, however, is still
unclear.
Tyrosol is another QSM produced by C. albicans. It has been ob-
served that when a dense culture of C. albicans is diluted into fresh
medium there is long lag-phase before exponential growth initi-
ates (Chen et al., 2004). This lag period can be shortened, and germ
tube formation can be enhanced, when tyrosol is supplied (Chen
et al., 2004). Alem et al. (2006) also suggested that tyrosol stimu-
lated hypha formation in the early and intermediate phases of C.
albicans biofilm formation. It seems that tyrosol does not induce
germ tube formation when C. albicans grows under non-filamen-
tous-inducing conditions but rather accelerates the morphological
switch from yeast-to-hyphal growth under favourable environ-
mental conditions (Chen et al., 2004). In contrast to farnesol, little
is known about how tyrosol exerts its effects. A study of gene
expression profiles of C. albicans cells at different cell densities
with and without tyrosol suggested that the acceleration of germ
tube formation may simply be due to upregulation of genes asso-
ciated with DNA replication (e.g. DNA polymerase, chromosome-
separation factor) and the cell cycle (e.g. cell cycle checkpoint
protein) (Chen et al., 2004).
Together, these studies demonstrate that the morphogenesis of
C. albicans is under the positive and negative regulation of QSMs in
response to cell density. QSMs such as tryptophol, phenylethyl
alcohol, and farnesol suppress hyphal formation when cells grow
at high density. The QSM tyrosol accelerates germ tube formation
at low cell density (Fig. 2). QSMs appear to have other roles in
addition to affecting morphogenesis. Farnesol, for example, en-
hances C. albicans resistance to oxidative stress (Westwater
et al., 2005), and tyrosol can act as an antioxidant, protecting C.
albicans cells during phagocytosis by neutrophils (Cremer et al.,
1999). Moreover, when growing in the human body C. albicans of-
ten grows in a polymicrobial environment and QSMs appear to be
also involved in inter-species competition (Shank and Kolter,
2009). Farnesol not only inhibits filament formation in other Can-
dida species (e.g. Candida dubliniensis and Candida tropicalis)
(Henriques et al., 2007; Zibafar et al., 2009),it also induces apop-
tosis in some fungi (e.g. S. cerevisiae,Aspergillus nidulans, and Pen-
icillium expansum), and suppresses the growth of Paracoccidioides
brasiliensis (Derengowski et al., 2009; Fairn et al., 2007; Liu
et al., 2009; Semighini et al., 2006). In contrast, when C. albicans
is exposed to other QSMs such as 3-OXO-C12 homoserine lactone
from Pseudomonas aeruginosa, its filamentous growth is sup-
pressed (Hogan et al., 2004). Interestingly, farnesol seems to be
also involved in C. albicans-host interactions. Proteomic ap-
proaches have shown that farnesol triggers apoptosis in both hu-
man oral carcinoma cells and C. albicans itself via classic
apoptotic pathways (Scheper et al., 2008; Shirtliff et al., 2009). It
appears that C. albicans is more susceptible to farnesol-mediated
cell death when log-phase cells grow under nutrient-poor condi-
tions (Langford et al., 2010). Dècanis et al. (2009) demonstrated
that farnesol upregulates the expression of toll-like receptor 2,
and increases the production of interleukin-6 and b-defensin 2
in the engineered tissue of human oral mucosa. The same authors
suggest that farnesol promotes epithelial cell immunity against C.
albicans (Dècanis et al., 2009). Moreover, Ghosh et al. (2010)
showed that farneosl induces the expression of inflammatory
cytokines in the macrophage. Therefore, these studies clearly dem-
onstrate that QSMs play complex roles in C. albicans-host and C.
albicans-interspecies interactions.
Fig. 2. The effect of quorum sensing molecules on the dimorphic transition of C.
albicans. Tyrosol accelerates hypha formation, while farnesol, tryptophol, and
phenylethyl alcohol suppress hypha development.
T.-L. Han et al. / Fungal Genetics and Biology 48 (2011) 747–763 753
4. In silico reconstruction of the central carbon metabolism of C.
albicans and the biosynthesis of quorum sensing molecules
The central carbon metabolism of most organisms is highly con-
served comprising both catabolic and anabolic biochemical reac-
tions. Central carbon metabolism is indispensable for cellular
growth and any major cellular event, such as morphogenesis, will
certainly be accompanied by significant changes in these important
pathways. Therefore, knowledge of the different biochemical path-
ways involved in the central carbon metabolism of C. albicans, as well
as how they are affected by the morphogenetic process, is crucial to
understand the mechanisms of morphogenesis in this fungus.
Mostof the genesthought toencode enzymesinvolved inthe cen-
tral carbon metabolism of C. albicans have been annotated by indi-
vidual in vitro studies and by high-throughput transcriptomics
(Bensen et al., 2004; Doedt et al., 2004; Enjalbert et al., 2006; Fradin
et al., 2005; García-Sánchez et al., 2004; García-Sánchez et al., 2005;
Harcus et al., 2004; Hromatka et al., 2005; Karababa et al., 2004; Lan
etal., 2004;Lorenz etal., 2004;Murad etal., 2001; Nantel et al., 2002;
Nett et al., 2009; Rogers and Barker, 2002; Sexton et al., 2007; Shirt-
liff et al., 2009; Singh et al., 2005; Swoboda et al., 1994; Tournu et al.,
2005) and proteomics studies (Cabezón et al., 2009; Ferna
´ndez-
Arenas et al., 2007; Hernández et al., 2004; Kusch et al., 2008; Pitarch
et al., 2004; Shirtliff et al., 2009; Thomas et al., 2006; Urban et al.,
2003; Yin et al., 2004). We have reconstructed in silico the central
carbon metabolism of C. albicans directly from its non-annotated
genome sequence available from GenBank,using a program called
IdentiCS (Sun and Zeng, 2004). Then the metabolic pathways were
curated based on three publicly available online-databases: the Can-
dida Genome Database – CGD (http://www.candidagenome.org/),
the Saccharomyces Genome Database – SGD (http://www.yeastge-
nome.org/), and the Kyoto Encyclopedia of Genes and Genomes-
KEGG (http://www.genome.jp/kegg/)(Fig. 3).
4.1. Glycolysis
Genes encoding all glycolytic enzymes in C. albicans have been
identified and are conserved across fungi. Although the mRNA
expression of glycolytic genes is not regulated tightly and fluctuates
during the yeast-to-hyphal switch (Swoboda et al., 1994), some dif-
ferences in the activities of glycolytic enzymes have been correlated
with yeast and hyphal growth (Schwartz and Larsh, 1982). For in-
stance, the specific activity of hexokinases in the hyphal form is al-
most twice that in the yeast form (Schwartz and Larsh, 1982). This
might indicate a higher glycolytic flux during hyphal growth. Several
glycolytic genes are regulated by signaling pathways associated
with morphogenesis. These include enzymes such as hexokinase II
(upregulated by Efg1p and downregulated by Ssn6p and Rgt1p)
(Doedt et al., 2004; García-Sánchez et al., 2005; Sexton et al.,
2007), phosphofructokinase (downregulated by Rgt1p) (Sexton
et al., 2007), glucose-6-phosphote isomerase (upregulated by Efg1p)
(Doedt et al., 2004), fructose–bisphosphate aldolase (upregulated by
Efg1p, Gcn4p, Hog1p) (Doedt et al., 2004; Enjalbert et al., 2006; Yin
et al., 2004), phosphoglycerate kinase (upregulated by Gcn4p and
Hog1p) (Enjalbert et al., 2006; Yin et al., 2004), and pyruvate kinase
(upregulated by Gcn4p and Hog1p) (Enjalbert et al., 2006; Yin et al.,
2004). In addition, Shirtliff et al. (2009) used a proteomic analysis to
demonstrate that several glycolytic enzymes (e.g. glyceraldehyde 3-
phosphate dehydrogenase, enolase, phosphoglycerate mutase and
pyruvate kinase) were downregulated when C. albicans was exposed
to farnesol.
4.2. Pentose phosphate pathway
In anaerobic respiration, the pentose phosphate pathway is cou-
pled with glycolysis to generate both cytosolic NADPH and ribose.
The NADPH provides oxidizing energy for biosynthetic reactions
(e.g. synthesis of amino acids, fatty acids, and sugar alcohols) while
ribose is used in the biosynthesis of nucleotides (e.g. nucleic acids
and redox cofactors). The conversion of glucose 6-phosphate to
6-phosphogluconolactone by a NADP-dependent glucose 6-phos-
phate dehydrogenase (G6PDH) is the first reaction, and the
key-regulatory step, in the pentose phosphate pathway. A putative
G6PDH is encoded by the ZWF1 gene in C. albicans and its expres-
sion is upregulated by Gcn2p and Gcn4p (Tournu et al., 2005).
4.3. Pyruvate dehydrogenase
In aerobic respiration, pyruvate produced by glycolysis and the
pentose phosphate pathway is mainly oxidatively decarboxylated
to acetyl-CoA by the pyruvate dehydrogenase multi-complex en-
zyme. This enzyme is highly conserved across species, and the C.
albicans genome contains genes with high homology to the S. cere-
visiae operon encoding all subunits of pyruvate dehydrogenase.
Disruption of one of the pyruvate dehydrogenase subunit genes
(PDX1)inC. albicans resulted in a deficiency in filamentous growth
(Vellucci et al., 2007). Thus the availability of acetyl-CoA may be
required for the morphogenesis of C. albicans.
4.4. TCA cycle
The tricarboxylic acid (TCA) cycle is a central hub of carbon
metabolism (Fig. 3) and, under aerobic conditions, acetyl-CoA
formed from pyruvate is oxidized completely to carbon dioxide,
water, and chemical energy through this pathway. This process is
catalyzed by a series of conserved enzymes. All genes involved in
the TCA cycle have been found in the C. albicans genome and all
the TCA cycle enzymes have been extracted from C. albicans cells
(Rao et al., 1962). Some TCA cycle enzymes are regulated by signal-
ing pathways. For example,
a
-ketoglutarate dehydrogenase, succi-
nate dehydrogenase, fumarase, citrate synthase, and malate
dehydrogenase are repressed by the Efg1p transcription factor
(Doedt et al., 2004), which appears to be involved in hyphal forma-
tion (Leng et al., 2001; Stoldt et al., 1997). Citrate synthase is
downregulated by Hog1p and cis-aconitase is upregulated by
Gcn4p (Enjalbert et al., 2006). The TCA cycle is, however, amphi-
bolic because the cycle not only catabolically decarboxylates pyru-
vate but it also has anabolic functions. Intermediate compounds of
the TCA cycle are used as precursors for the biosynthesis of build-
ing blocks for the cell (e.g. amino acids and lipids). Therefore, a
constant inflow of carbon to supply intermediate compounds for
amino acid and lipid biosynthesis is essential for cell growth. An
example of a metabolic strategy to maintain the supply of TCA cy-
cle intermediates is the glyoxylate shunt.
4.5. Glyoxylate shunt
The glyoxylate shunt assimilates two-carbon molecules such as
ethanol and acetate into the TCA cycle; this process not only sup-
plies TCA cycle substrates but also allows microbial growth in envi-
ronments where only two-carbon compounds are available. The
glyoxylate shunt can be considered as a shortcut version of the
TCA cycle. The cycle bypasses two decarboxylation steps and di-
rectly converts isocitrate to malate using two enzymes: isocitrate
lyase (encoded by ICL1) and malate synthase (encoded by MLS1)
(Fig. 3). The regulation of the glyoxylate shunt is primarily via
the activity of isocitrate lyase, which is downregulated by the pres-
ence of the quorum sensing molecule farnesol (Enjalbert and
Whiteway, 2005) and is usually repressed by glucose in fungi.
Although there has been no direct report on the role of the glyoxy-
late shunt in C. albicans morphogenesis, Lorenz and Fink (2001)
754 T.-L. Han et al. / Fungal Genetics and Biology 48 (2011) 747–763
Fig. 3. The in silico reconstruction of the central carbon metabolism of C. albicans. Blue shading indicates the intermediate metabolites of glycolysis and the TCA cycle that act
as key precursors for the biosynthesis of amino acids. The intermediates for biosynthesis of individual amino acids are differentiated by different colours and red 3D boxes
represent the final amino acid products. Blue 3D boxes indicate quorum sensing molecules derived from aromatic amino acids and the putative genes encoding enzymes are
in red text. The few reactions not verified by in vitro studies are indicated by red lines.
T.-L. Han et al. / Fungal Genetics and Biology 48 (2011) 747–763 755
showed that the disruption of both ICL1 and MLS1 reduced C. albi-
cans virulence using a mouse model of intravenous infection.
4.6. Amino acid biosynthesis
The biosynthesis of amino acids is achieved through a series of
biochemical reactions that can be classified into six distinct path-
ways. Each amino acid pathway derives its carbon skeleton from
a common precursor which is an intermediate compound of glycol-
ysis or the TCA cycle. In C. albicans, the glycolytic pathway provides
precursors for the biosynthesis of four amino acid families: the his-
tidine, serine, pyruvate and aromatic families. Only the aspartate
and glutamate family precursors are derived from the TCA cycle
(Fig. 3).
4.6.1. Glutamate biosynthesis
Glutamate is synthesized directly from
a
-ketoglutarate by an
NADPH-dependent glutamate dehydrogenase (GDH). This is an
important reaction in central carbon metabolism because it serves
to assimilate ammonia for the biosynthesis of several other amino
acids and at the same time it maintains the redox equilibrium in
the cell. The NADH-dependent glutamate dehydrogenase (Gdh2p)
favors the catabolic deamination of glutamate to
a
-ketoglutarate.
Therefore, Gdh2p is an important enzyme in the biosynthesis of
other amino acids (e.g. aspartate, tyrosine, phenylalanine, etc.).
Three glutamate dehydrogenase genes have been identified in S.
cerevisiae but only GDH2 and GDH3 have orthologues in the C. albi-
cans genome. NADH-dependent GDH2 is transcriptional repressed
by Tup1p, Nrg1p and Mig1p (Murad et al., 2001). NADP-dependent
GDH3 is downregulated by Efg1p (Doedt et al., 2004), and upregu-
lated 2-fold by Rim101p at pH 8 (Bensen et al., 2004).
4.6.2. Aromatic amino acid and quorum sensing molecule biosynthesis
The discovery that extracellular aromatic alcohols act as
quorum sensing molecules during fungal morphogenesis makes
aromatic amino acid biosynthesis an important component of
the central carbon metabolism regarding morphogenesis.But
how the aromatic alcohols are synthesized from aromatic amino
acids in C. albicans is still unclear. In contrast, the production of
aromatic alcohols in S. cerevisiae has been well-characterized.
Aromatic alcohols are derived from aromatic amino acid
catabolism via the Ehrlich pathway (Felix, 1907). This process in
S. cerevisiae involves three consecutive enzymatic steps; a trans-
aminase (encoded by ARO8, ARO9), a decarboxylase (encoded by
ARO10), and reduction by alcohol dehydrogenase (encoded by
ADH)(Hazelwood et al., 2008; Sentheshanmuganathan, 1960). It
is proposed that the biosynthesis of aromatic alcohols such as
tyrosol, tryptophol, and phenylethyl alcohol in C. albicans
(Fig. 2), follows the same biosynthetic pathway as in S. cerevisiae
(Ghosh et al., 2008). This study demonstrated that the biosynthe-
sis of aromatic alcohols by C. albicans decreased when the ARO80
gene, which encodes a transcriptional activator known to increase
the expression of Aro9p and Aro10p in S. cerevisiae, was deleted
(Ghosh et al., 2008).
4.6.3. Regulation of global amino acid biosynthesis
There are several morphology-associated genes that also regu-
late multiple amino acid biosynthetic pathways in response to
starvation and pH changes. When amino acids are limiting growth,
C. albicans switches from yeast to filamentous growth (Tripathi
et al., 2002). This phenomenon is regulated by the transcriptional
activator Gcn4p in an EFG1-dependent fashion (Tripathi et al.,
2002). The double deletion gcn4/gcn4 blocks amino acid starvation
from inducing morphogenesis, but the efg1/efg1 knockout mutants
fail to express this GCN4 phenotype (Tripathi et al., 2002). Gcn4p is
not only involved in the dimorphic switch of C. albicans, but it also
acts as a global regulator of metabolism in response to amino acid
starvation (Tournu et al., 2005; Tripathi et al., 2002). Tripathi et al.
(2002) found from DNA microarray analysis that, under amino acid
starvation conditions, Gcn4p upregulates numerous enzymes in-
volved in amino acid biosynthesis, except those responsible for
the biosynthesis of cysteine, glycine, alanine, aspartate and gluta-
mine (Table 3)(Tournu et al., 2005). Rim101p is a pH-response reg-
ulator that is activated at alkaline pH (Li and Mitchell, 1997). In
turn, Rim101p regulates the expression of pH-response regulators
(Phr1p and Phr2p) involved in the pH-dependent morphogenesis
of C. albicans (Ramon et al., 1999).Bensen et al. (2004) compared
transcriptional profiles between rim101/rim101 null-mutants and
the wild type strain. They found that Rim101p upregulates argi-
nine, glutamine, and histidine biosynthetic enzymes at pH 8, while
asparagine and histidine biosynthetic enzymes are downregulated
at pH4, respectively (Table 3).
The in silico reconstruction of central carbon metabolic path-
ways based on the C. albicans genome (Fig 3) enables us to inte-
grate post-genomic studies into a metabolic network that helps
elucidate the physiological and biochemical mechanisms govern-
ing the morphological switch of C. albicans.
5. Central carbon metabolism, virulence, and morphogenesis of
C. albicans
In additional to its role in morphogenesis, central carbon
metabolism has increasingly been recognized for its importance
in fungal pathogenicity. It has been shown that the deletion of gly-
colytic transcriptional regulators (TYE7,GAL4), a gluconeogenic
gene (FBP1), glyoxlate cycle genes (ICL1, MLS1), or a b-oxidation
gene (FOX2), attenuates the virulence of C. albicans in a murine
model of systemic infection (Askew et al., 2009; Lorenz and Fink,
2001; Piekarska et al., 2006; Ramírez and Lorenz, 2007). Interest-
ingly, C. albicans appears to modulate these carbon assimilatory
pathways during infection. When glucose is at similar levels to that
found in the bloodstream there is an activation of glycolysis and
repression of both the glyoxylate cycle and gluconeogenesis in C.
albicans (Barelle et al., 2006; Rodaki et al., 2009). In contrast, sev-
eral transcriptomic studies have demonstrated that following the
phagocytosis of C. albicans by neutrophils or macrophages, there
is a downregulation of glycolysis, and an upregulation of the glyox-
late cycle, gluconeogensis, and b-oxidation (Fradin et al., 2005; Lor-
enz et al., 2004; Rubin-Bejerano et al., 2003). Since all these
metabolic pathways involve the utilization of non-fermentable
carbon sources (e.g. amino acids, ethanol, acetate, and fatty acids),
it seems likely that C. albicans can alter its central carbon metabo-
lism to utilize alternative carbon sources in response to host de-
fences or to changes in the environment, and this metabolic
reprogramming is important for the virulence of C. albicans.
Although the morphological switch from yeast-to-hyphae is ob-
served after C. albicans is engulfed by macrophages, Lorenz et al.
(2004) suggested that those underling metabolic changes are inde-
pendent from morphogenesis.
Lorenz et al. (2004) also demonstrated that genes for
L
-arginine
biosynthesis and degradation were upregulated after C. albicans
cells were engulfed by macrophages, and other groups have shown
that concentrations of CO
2
greater than 50% (v/v) enhanced fila-
mentous growth (Bahn and Mühlschlegel, 2006; Klengel et al.,
2005; Mock et al., 1990; Sims, 1986). Ghosh et al. (2009) have pro-
posed a mechanism, involving arginine, which connects these two
observations. They suggest that arginase (Car1p) converts arginine
to urea, which in turn is cleaved into NH
3
and CO
2
by the amidol-
yase enzyme (Dur1,2p [sic]). They show that the dur1,2/dur1,2
null-mutant cannot form germ tubes in macrophages, and that
the phenomenon of arginine-induced hyphal formation is not
756 T.-L. Han et al. / Fungal Genetics and Biology 48 (2011) 747–763
observed in efg1/efg1 strains. Therefore, once inside a macrophage,
it is proposed that C. albicans produces arginine and arginine
degradation produces CO
2
. The CO
2
may then activate adenylyl
cyclase (Cdc35p), which in turn activates the cAMP-PKA signaling
pathway and Efg1p to induce the yeast-to-hyphal transition
(Fig. 1) and thereby C. albicans escapes from the macrophage
(Klengel et al., 2005).
6. The effect of metabolic genes on the utilization of carbon
sources
There are several metabolic genes associated with morphogen-
esis or virulence that seem to affect the ability of C. albicans to uti-
lize carbon sources. Firstly, trehalose-6-phosphate synthase (TPS1)
is a gene involved in the first step of trehalose biosynthesis and it
regulates glucose influx (Ernandes et al., 1998). The tps1/tps1 null-
mutant is unable to grow on glucose or fructose as a sole carbon
source but this mutant is capable of growing on other carbon
sources such as galactose or glycerol (Zaragoza et al., 1998). In
addition, this mutant is impaired in hyphal formation (Zaragoza
et al., 1998). Another gene related to trehalose biosynthesis is the
cell wall-linked acid trehalase (ATC1)(Pedreño et al., 2004). The
atc1/atc1 null-mutant is incapable of growing on exogenous treha-
lose as sole carbon source and the mutant has diminished capacity
to form hyphae in various media (e.g. serum, spider medium and
Lee’s medium) (Pedreño et al., 2007).
Galactose metabolism also plays a role in the morphogenesis of
C. albicans. UDP-galactose-4-epimerase (GAL10) is a key enzyme in
galactose metabolism that converts UDP-galactose into UDP-glu-
cose. The glucose generated can then be fed into glycolysis as a car-
bon and energy source. The gal10/gal10 null-mutant is unable to
grow on galactose as sole carbon source (Singh et al., 2007). Com-
pared to wild type, the mutant also exhibits increased hyphal for-
mation in rich media, Lee’s medium and spider medium (Singh
et al., 2007). Recently, Hgt4p has been reported as a galactose
and glucose sensor. Indeed, the hgt4/hgt4 null-mutant cannot grow
on either glucose or galactose in the presence of the respiration
inhibitor antimycin A (Brown et al., 2009, 2006). The hgt4/hgt4 mu-
tant is hypo-filamentous and less virulent in a mouse model of dis-
seminated candidiasis (Brown et al., 2006).
In addition, carnitine biosynthesis and acetyl-CoA metabolism
can affect the ability of C. albicans to utilize different carbon
sources. Carnitine is an essential metabolite that acts as a shuttle
to transport fatty acids and acetyl groups between intracellular
compartments. Mutants lacking carnitine synthetic enzymes (e.g.
trimethyl-lysine dioxygenase, trimethylaminobutyraldehye dehy-
drogenease, and butyrobetaine dioxygenase) or lacking carnitine
acetyltransferase, which transfers the acetyl group from acetyl-
CoA to carnitine, are unable to utilize non-fermentable carbon
sources such as fatty acids, acetate, or ethanol as sole carbon
sources (Strijbis et al., 2009; Zhou and Lorenz, 2008). Moreover,
Carman et al. (2008) have shown that a C. albicans mutant strain
with acetyl-CoA synthase (ACS2) deleted was unable to utilize glu-
cose, acetate, or ethanol but the mutant cells were viable when gi-
ven fatty acids or glycerol. The same authors deleted acetyl-CoA
hydrolase (ACH1), an enzyme which hydrolysis acetyl-CoA to ace-
tate, but this strain was fully virulent in a mouse model of dissem-
inated candidiasis.
7. In silico reconstruction of the sterol biosynthetic pathway
and farnesol biosynthesis in C. albicans
The sterol biosynthesis pathway generates compounds neces-
sary for the maintenance of cellular structure. These sterols, such
as ergosterol in fungi and cholesterol in mammalian cells, are
essential for membrane integrity and permeability. The sterol bio-
synthesis pathway is targeted by several antifungal agents. In addi-
tion, sterol biosynthesis is potentially involved in the quorum
sensing of dimorphic fungi because this pathway generates farne-
sol, the most well-characterized quorum sensing molecule in-
volved in C. albicans morphogenesis.
Adopting the same approach we used for the central carbon
metabolism, we have reconstructed, in silico, the C. albicans sterol
biosynthetic pathway (Fig. 4). The first step in sterol biosynthesis
is the condensation of acetyl-CoA and acetoacetyl-CoA into 3-hy-
droxy-3-methylglutaryl-CoA by hydroxymethylglutaryl-CoA syn-
thase. Seven sequential reactions are then involved in the
synthesis of farnesyl pyrophosphate, which is the precursor for
the biosynthesis of farnesol. Surprisingly, the enzyme that synthe-
sizes farnesol has not been fully described, but Hornby et al. (2003)
claimed to have extracted an enzyme from C. albicans possessing
this activity. Fungal and mammalian cells share a common sterol
biosynthetic pathway from acetyl-CoA through farnesyl pyrophos-
phate to zymosterol (Fig. 4). From this point there are different
pathways in fungi and mammals. 24-C-methyltransferase converts
zymosterol into fecosterol leading to the biosynthesis of ergosterol
in fungi, whereas 24-dehydrocholesterol reductase directs sterol
biosynthesis into the production of cholesterol which serves as a
precursor for steroid hormones (e.g. androgens and estrogens) in
mammalian cells. In general, the biosynthesis of ergosterol is con-
served between C. albicans and S. cerevisiae.
Interestingly, the presence of estrogens has been reported to
have a profound effect on the morphogenesis of dimorphic fungi
(Cheng et al., 2006; White and Larsen, 1997). Estrogen may con-
tribute to the gender bias in human infection by another dimorphic
and pathogenic fungus, P. brasiliensis, for which, contrary to C. albi-
cans, the yeast form is the pathogenic state. In healthy individuals,
P. brasiliensis infects mainly adult males (Borges-Walmsley et al.,
2002). Estrogen has been shown to suppress the hyphal-to-yeast
transition in P. brasiliensis and, thus, it has been proposed that
adult women are less prone to infection by P. brasiliensis due to
higher levels of estrogen in their bodies compared to males (Bor-
ges-Walmsley et al., 2002).
On the other hand, healthy women often develop recurrent vag-
inal candidosis, especially during pregnancy (Tarryet al., 2005). Clin-
ical studies have shown that women are more likely to have
symptomatic Candida infections when estrogen levels are high (Tar-
ry et al., 2005), and estrogen has been shown to promote germ tube
formation in C. albicans (Cheng et al., 2006; White and Larsen, 1997)
which is the first step in the yeast-to-hypha transition (Whiteway
and Bachewich, 2007). Low estrogen levels may be one reason why
healthy adult males do not commonly develop candidosis.
Therefore estrogen, which seems to promote Candida infection
in women, protects them from P. brasiliensis infection because this
hormone induces the filamentous growth of both fungi. What is
intriguing from the metabolic point of view is the fact that estro-
gens are synthesized by mammalian cells via the sterol biosyn-
thetic pathway, which is used by fungi to synthesize farnesol
(Nickerson et al., 2006). Thus, the sterol pathway appears to have
an important role in both fungal morphogenesis and in
pathogenesis.
8. The integration of quorum sensing and central carbon
metabolism in C. albicans
QSMs are products of the central carbon metabolism of C. albi-
cans. They function as communication signals and coordinately
regulate the growth of C. albicans cells, in response to cell density.
Their production, however, may simply reflect the flux within the
central carbon metabolism pathways and their accumulation and
T.-L. Han et al. / Fungal Genetics and Biology 48 (2011) 747–763 757
signaling may provide feedback to these pathways to optimise
growth under the particular environmental conditions. For exam-
ple, if carbon and nitrogen sources are available to the cells this
may stimulate flux though the pathways for the biosynthesis of
QSMs such as farnesol that will repress the filamentous growth
of C. albicans and, if carbon and/or nitrogen sources become scarce,
flux through other pathways involved in the biosynthesis of QSMs
that accelerate hypha formation, such as tyrosol, may be activated.
Themetabolic hubs of central carbon metabolism are metabolites
that take part in more than twenty different pathways and include
pyruvate, NADH, NADPH, and ATP (Villas-Bôas et al., 2007). Thus,
central carbon metabolism is highly interconnected and forms a
metabolic network that responds very quickly to any environmental
change.This isthe part of cell metabolism most likely to include met-
abolic reactions involved in cell responses to QSMs in the environ-
ment. Indeed, several observations support the idea that central
carbon metabolism provides the carbon sources for the synthesis
of QSMs. As discussed above, farnesol, tyrosol, tryptophol, and
phenyethyl alcohol are derived from glycolytic products. Aromatic
QSMs are derived from phosphoenolpyruvate and farnesol is derived
from acetyl-CoA. Therefore, if these molecules are synthesized as
part of central carbon metabolism, their concentrations are likely
to affect the flux distribution in these primary metabolic pathways
by suppressing or inducing specific metabolic reactions. In addition,
N-acyl homoserine lactones, which are common QMSs produced by
many bacteria (e.g. Pseudomonas corrugata,Erwina carotovora and
others (Dong et al., 2001; Licciardello et al., 2007; Schaefer et al.,
1996)), are synthesized directly from methionine, which is derived
from oxaloacetic acid in the TCA cycle, and are thus also part of cen-
tral carbon metabolism. Moreover, the production of QSMs seems to
be affected by the availability of their precursors. For instance, the
presence of aromatic amino acids increases the level of tyrosol, try-
ptophol, and phenyethyl alcohol in C. albicans (Ghosh et al., 2008).
Despite the obvious connection between quorum sensing and
central carbon metabolism, the role of primary metabolism in
the mechanism of quorum sensing has not been investigated. We
hypothesize that once extracellular QSMs reach a certain concen-
tration, their passive diffusion across the cell membrane could af-
fect the expression of specific genes or the activity of specific
enzymes involved in morphogenesis. Indeed, fluorescently labeled
farnesol analogs supplied to C. albicans cultures have been found in
the cytoplasm of C. albicans (Shchepin et al., 2003). Thus, QSMs
could rapidly up- and down-regulate particular metabolic path-
ways (e.g. aromatic amino acid biosynthesis and sterol biosynthe-
sis), redistributing the metabolic flux of carbon through central
carbon metabolism and inducing the morphological switch by
altering the biosynthesis of cell wall components. Several transcri-
ptomics studies have shown that the metabolic pathways from
central carbon metabolism are highly affected by the presence of
quorum sensing molecules (Table 3). Therefore, the study on the
effect of QSMs on C. albicans morphogenesis in the context of cen-
tral carbon metabolism has the potential to unravel important
metabolic mechanisms underlying the morphogenetic process,
and thus, should be pursued further.
9. Final remarks
The ability to study the behaviour of biological systems in vivo
under different environmental conditions has increased with re-
cent developments in genomics and post-genomic tools. Gene
knockout experiments can demonstrate the involvement of indi-
vidual genes in biological processes, but often it is unclear how
the genes mediate their effects. Proteomic studies can confirm that
changes in transcription associated with gene disruption, or envi-
ronmental changes, result in altered protein expression. The inte-
gration of gene knockout, transcriptomic and proteomic studies
has elegantly elucidated signaling pathways involved in C. albicans
morphogenesis. This still, however, only gives a linear view of mor-
phogenesis. This review has used the C. albicans genome data to
Fig. 4. The in silico reconstruction of the sterol pathway of C. albicans and mammalian cells. Farnesol, which suppress germ tube formation in C. albicans, is produced via the
sterol pathway, but some enzymes involved in its biosynthesis are still to be identified. Mammals use the same pathway to synthesize estrogens, which promote germ tube
formation in C. albicans.
758 T.-L. Han et al. / Fungal Genetics and Biology 48 (2011) 747–763
reconstruct the network of metabolic pathways involved in central
carbon, sterol, and QSM metabolism. This will provide a framework
which can guide the interpretation of metabolomic data and thus
generate the fluxome and a more three-dimensional appreciation
of how QSMs and environmental cues mediate their effects on
morphology.
Morphogenesis is considered to be an important virulence fac-
tor for C. albicans and other dimorphic fungi. Central carbon metab-
olism and sterol biosynthesis not only supply carbon and lipid
sources to generate the building blocks of new cellular structures
in response to morphogenesis, but also supply precursors for the
biosynthesis of the quorum sensing molecules involved in cell-cell
communication and the coordinated dimorphic transition in a pop-
ulation of C. albicans cells. Together, the pre-existing genomic se-
quences and the in silico reconstruction of C. albicans biochemical
pathways should enable a powerful systems biology study of this
fungus that would be the cornerstone to assist in the elucidation
of the metabolic mechanisms responsible for C. albicans morpho-
genesis and virulence.
References
Alem, M.A.S., Oteef, M.D.Y., Flowers, T.H., Douglas, L.J., 2006. Production of tyrosol
by Candida albicans biofilms and its role in quorum sensing and biofilm
development. Eukaryotic Cell 5, 1770–1779.
Alonso-Monge, R., Navarro-García, F., Román, E., Negredo, A.I., Eisman, B., Nombela,
C., Pla, J., 2003. The Hog1 mitogen-activated protein kinase is essential in the
oxidative stress response and chlamydospore formation in Candida albicans.
Eukaryotic Cell 2, 351–361.
Alonso-Monge, R., Carvaihlo, S., Nombela, C., Rial, E., Pla, J., 2009a. The Hog1 MAP
kinase controls respiratory metabolism in the fungal pathogen Candida albicans.
Microbiology 155, 413–423.
Alonso-Monge, R., Román, E., Arana, D.M., Pla, J., Nombela, C., 2009b. Fungi sensing
environmental stress. Clinical Microbiology and Infection 15, 17–19.
Alvarez, F.J., Konopka, J.B., 2007. Identification of an N-acetylglucosamine
transporter that mediates hyphal induction in Candida albicans. Molecular
Biology of the Cell 18, 965–975.
Arai, T., Mikami, Y., Yokoyama, K., 1977. Phagocytosis of Candida albicans by rabbit
alveolar macrophages and guinea pig neutrophils. Sabouraudia Journal of
Medical and Veterinary Mycology 15, 171–177.
Arana, D.M., Nombela, C., Alonso-Monge, R., Pla, J., 2005. The Pbs2 MAP kinase
kinase is essential for the oxidative-stress response in the fungal pathogen
Candida albicans. Microbiology 151, 1033–1049.
Askew, C., Sellam, A., Epp, E., Hogues, H., Mullick, A., Nantel, A., Whiteway, M., 2009.
Transcriptional regulation of carbohydrate metabolism in the human pathogen
Candida albicans. PLoS Pathogens, 5.
Asleson, C.M., Bensen, E.S., Gale, C.A., Melms, A.S., Kurischko, C., Berman, J., 2001.
Candida albicans INT1-induced filamentation in Saccharomyces cerevisiae
depends on Sla2p. Molecular and Cellular Biology 21, 1272–1284.
Bachewich, C., Whiteway, M., 2005. Cyclin Cln3p links G1 progression to hyphal and
pseudohyphal development in Candida albicans. Eukaryotic Cell 4, 95–102.
Bahn, Y.S., Mühlschlegel, F.A., 2006. CO
2
sensing in fungi and beyond. Current
Opinion in Microbiology 9, 572–578.
Bahn, Y.S., Sundstrom, P., 2001. CAP1, an adenylate cyclase-associated protein gene,
regulates bud-hypha transitions, filamentous growth, and cyclic AMP levels and
is required for virulence of Candida albicans. Journal of Bacteriology 183, 3211–
3223.
Bahn, Y.S., Staab, J., Sundstrom, P., 2003. Increased high-affinity phosphodiesterase
PDE2 gene expression in germ tubes counteracts CAP1-dependent synthesis of
cyclic AMP, limits hypha production and promotes virulence of Candida
albicans. Molecular Microbiology 50, 391–409.
Bahn, Y.S., Xue, C., Idnurm, A., Rutherford, J.C., Heitman, J., Cardenas, M.E., 2007.
Sensing the environment: lessons from fungi. Nature Reviews Microbiology 5,
57–69.
Bainton, N.J., Bycroft, B.W., Chhabra, S.R., Stead, P., Gledhill, L., Hill, P.J., Rees, C.E.D.,
Winson, M.K., Salmond, G.P.C., Stewart, G.S.A.B., Williams, P., 1992. A general
role for the lux autoinducer in bacterial cell signalling: control of antibiotic
biosynthesis in Erwinia. Gene 116, 87–91.
Banerjee, M., Thompson, D.S., Lazzell, A., Carlisle, P.L., Pierce, C., Monteagudo, C.,
LoÌpez-Ribot, J.L., Kadosh, D., 2008. UME6, a novel filament-specific regulator of
Candida albicans hyphal extension and virulence. Molecular Biology of the Cell
19, 1354–1365.
Barelle, C.J., Priest, C.L., MacCallum, D.M., Gow, N.A.R., Odds, F.C., Brown, A.J.P., 2006.
Niche-specific regulation of central metabolic pathways in a fungal pathogen.
Cellular Microbiology 8, 961–971.
Bassilana, M., Blyth, J., Arkowitz, R.A., 2003. Cdc24, the GDP-GTP exchange factor for
Cdc42, is required for invasive hyphal growth of Candida albicans. Eukaryotic
Cell 2, 9–18.
Bastidas, R.J., Heitman, J., 2009. Trimorphic stepping stones pave the way to fungal
virulence. Proceedings of the National Academy of Sciences of the United States
of America 106, 351–352.
Bendel, C.M., Hess, D.J., Garni, R.M., Henry-Stanley, M., Wells, C.L., 2003.
Comparative virulence of Candida albicans yeast and filamentous forms in
orally and intravenously inoculated mice. Critical Care Medicine 31, 501–
507.
Bensen, E.S., Martin, S.J., Li, M., Berman, J., Davis, D.A., 2004. Transcriptional profiling
in Candida albicans reveals new adaptive responses to extracellular pH and
functions for Rim101p. Molecular Microbiology 54, 1335–1351.
Bensen, E.S., Clemente-Blanco, A., Finley, K.R., Correa-Bordes, J., Berman, J., 2005.
The mitotic cyclins Clb2p and Clb4p affect morphogenesis in Candida albicans.
Molecular Biology of the Cell 16, 3387–3400.
Biswas, K., Morschhäuser, J., 2005. The Mep2p ammonium permease controls
nitrogen starvation-induced filamentous growth in Candida albicans. Molecular
Microbiology 56, 649–669.
Biswas, S., Roy, M., Datta, A., 2003. N-acetylglucosamine-inducible CaGAP1 encodes
a general amino acid permease which co-ordinates external nitrogen source
response and morphogenesis in Candida albicans. Microbiology 149, 2597–
2608.
Biswas, S., Van Dijck, P., Datta, A., 2007. Environmental sensing and signal
transduction pathways regulating morphopathogenic determinants of Candida
albicans. Microbiology and Molecular Biology Reviews 71, 348–376.
Borges-Walmsley, M.I., Chen, D., Shu, X., Walmsley, A.R., 2002. The pathobiology of
Paracoccidioides brasiliensis. Trends in Microbiology 10, 80–87.
Braun, B.R., Johnson, A.D., 1997. Control of filament formation in Candida albicans by
the transcriptional repressor TUP1. Science 277, 105–109.
Braun, B.R., Kadosh, D., Johnson, A.D., 2001. NRG1, a repressor of filamentous
growth in C. albicans, is down-regulated during filament induction. EMBO
Journal 20, 4753–4761.
Brown, A.J.P., Gow, N.A.R., 1999. Regulatory networks controlling Candida albicans
morphogenesis. Trends in Microbiology 7, 333–338.
Brown Jr., D.H., Giusani, A.D., Chen, X., Kumamoto, C.A., 1999. Filamentous growth
of Candida albicans in response to physical environmental cues and its
regulation by the unique CZF1 gene. Molecular Microbiology 34, 651–662.
Brown, V., Sexton, J.A., Johnston, M., 2006. A glucose sensor in Candida albicans.
Eukaryotic Cell 5, 1726–1737.
Brown, V., Sabina, J., Johnston, M., 2009. Specialized sugar sensing in diverse fungi.
Current Biology 19, 436–441.
Cabezón, V., Llama-Palacios, A., Nombela, C., Monteoliva, L., Gil, C., 2009. Analysis of
Candida albicans plasma membrane proteome. Proteomics 9, 4770–4786.
Calera, J.A., Calderone, R., 1999. Histidine kinase, two-component signal
transduction proteins of Candida albicans and the pathogenesis of candidosis.
Mycoses 42 (1), 49–53 (Suppl.).
Calera, J.A., Zhao, X.J., Calderone, R., 2000. Defective hyphal development and
avirulence caused by a deletion of the SSK1 response regulator gene in Candida
albicans. Infection and Immunity 68, 518–525.
Cao, Y.Y., Cao, Y.B., Xu, Z., Ying, K., Li, Y., Xie, Y., Zhu, Z.Y., Chen, W.S., Jiang, Y.Y., 2005.
CDNA microarray analysis of differential gene expression in Candida albicans
biofilm exposed to farnesol. Antimicrobial Agents and Chemotherapy 49, 584–
589.
Carlisle, P.L., Banerjee, M., Lazzell, A., Monteagudo, C., López-Ribot, J.L., Kadosh, D.,
2009. Expression levels of a filament-specific transcriptional regulator are
sufficient to determine Candida albicans morphology and virulence. Proceedings
of the National Academy of Sciences of the United States of America 106, 599–
604.
Carman, A.J., Vylkova, S., Lorenz, M.C., 2008. Role of acetyl coenzyme a synthesis and
breakdown in alternative carbon source utilization in Candida albicans.
Eukaryotic Cell 7, 1733–1741.
Cassola, A., Parrot, M., Silberstein, S., Magee, B.B., Passeron, S., Giasson, L., Cantore,
M.L., 2004. Candida albicans lacking the gene encoding the regulatory subunit of
protein kinase a displays a defect in hyphal formation and an altered
localization of the catalytic subunit. Eukaryotic Cell 3, 190–199.
Cheetham, J., Smith, D.A., Dantas, A.D.S., Doris, K.S., Patterson, M.J., Bruce, C.R.,
Quinn, J., 2007. A single MAPKKK regulates the Hog1 MAPK pathway in the
pathogenic fungus Candida albicans. Molecular Biology of the Cell 18, 4603–
4614.
Chen, H., Fink, G.R., 2006. Feedback control of morphogenesis in fungi by aromatic
alcohols. Genes & Development 20, 1150–1161.
Chen, D., Janganan, T.K., Chen, G., Marques, E.R., Kress, M.R., Goldman, G.H.,
Walmsley, A.R., Borges-Walmsley, M.I., 2007. The cAMP pathway is important
for controlling the morphological switch to the pathogenic yeast form of
Paracoccidioides brasiliensis. Molecular Microbiology 65, 761–779.
Chen, J., Zhou, S., Wang, Q., Chen, X., Pan, T., Liu, H., 2000. Crk1, a novel Cdc2-related
protein kinase, is required for hyphal development and virulence in Candida
albicans. Molecular and Cellular Biology 20, 8696–8708.
Chen, H., Fujita, M., Feng, Q., Clardy, J., Fink, G.R., 2004. Tyrosol is a quorum-sensing
molecule in Candida albicans. Proceedings of the National Academy of Sciences
of the United States of America 101, 5048–5052.
Cheng, G., Yeater, K.M., Hoyer, L.L., 2006. Cellular and molecular biology of Candida
albicans estrogen response. Eukaryotic Cell 5, 180–191.
Cloutier, M., Castilla, R., Bolduc, N., Zelada, A., Martineau, P., Bouillon, M., Magee,
B.B., Passeron, S., Giasson, L., Cantore, M.L., 2003. The two isoforms of the cAMP-
dependent protein kinase catalytic subunit are involved in the control of
dimorphism in the human fungal pathogen Candida albicans. Fungal Genetics
and Biology 38, 133–141.
T.-L. Han et al. / Fungal Genetics and Biology 48 (2011) 747–763 759
Court, H., Sudbery, P., 2007. Regulation of Cdc42 GTPase activity in the formation of
hyphae in Candida albicans. Molecular Biology of the Cell 18, 265–281.
Cremer, J., Vatou, V., Braveny, I., 1999. 2,4-(Hydroxyphenyl)-ethanol, an
antioxidative agent produced by Candida spp., impairs neutrophilic yeast
killing in vitro. FEMS Microbiology Letters 170, 319–325.
Csank, C., Makris, C., Meloche, S., Schroppel, K., Rollinghoff, M., Dignard, D., Thomas,
D.Y., Whiteway, M., 1997. Derepressed hyphal growth and reduced virulence in
a VH1 family-related protein phosphatase mutant of the human pathogen
Candida albicans. Molecular Biology of the Cell 8, 2539–2551.
Csank, C., Schröppel, K., Leberer, E., Harcus, D., Mohamed, O., Meloche, S., Thomas,
D.Y., Whiteway, M., 1998. Roles of the Candida albicans mitogen-activated
protein kinase homolog, Cek1p, in hyphal development and systemic
candidiasis. Infection and Immunity 66, 2713–2721.
Dabrowa, N., Taxer, S.S.S., Howard, D.H., 1976. Germination of Candida albicans
induced by proline. Infection and Immunity 13, 830–835.
Davis-Hanna, A., Piispanen, A.E., Stateva, L.I., Hogan, D.A., 2008. Farnesol and
dodecanol effects on the Candida albicans Ras1-cAMP signalling pathway and
the regulation of morphogenesis. Molecular Microbiology 67, 47–62.
De Bernardis, F., Mühlschlegel, F.A., Cassone, A., Fonzi, W.A., 1998. The pH of the
host niche controls gene expression in and virulence of Candida albicans.
Infection and Immunity 66, 3317–3325.
Dècanis, N., Savignac, K., Rouabhia, M., 2009. Farnesol promotes epithelial cell
defense against Candida albicans through Toll-like receptor 2 expression,
interleukin-6 and human Î
2
-defensin 2 production. Cytokine 45, 132–140.
Derengowski, L.S., De-Souza-Silva, C., Braz, S.V., Mello-De-Sousa, T.M., Báo, S.N.,
Kyaw, C.M., Silva-Pereira, I., 2009. Antimicrobial effect of farnesol, a Candida
albicans quorum sensing molecule, on Paracoccidioides brasiliensis growth and
morphogenesis. Annals of Clinical Microbiology and Antimicrobials, 8.
Dhillon, N.K., Sharma, S., Khuller, G.K., 2003. Signaling through protein kinases and
transcriptional regulators in Candida albicans. Critical Reviews in Microbiology
29, 259–275.
Doedt, T., Krishnamurthy, S., Bockmühl, D.P., Tebarth, B., Stempel, C., Russell,
C.L., Brown, A.J.P., Ernst, J.F., 2004. APSES proteins regulate morphogenesis
and metabolism in Candida albicans. Molecular Biology of the Cell 15, 3167–
3180.
Dong, Y.H., Wang, L.H., Xu, J.L., Zhang, H.B., Zhang, X.F., Zhang, L.H., 2001. Quenching
quorum-sensing-dependent bacterial infection by an N-acyl homoserine
lactonase. Nature 411, 813–817.
Eberhard, A., 1972. Inhibition and activation of bacterial luciferase synthesis.
Journal of Bacteriology 109, 1101–1105.
Eberhard, A., Burlingame, A.L., Eberhard, C., Kenyon, G.L., Nealson, K.H.,
Oppenheimer, N.J., 1981. Structural identification of autoinducer of
Photobacterium fischeri luciferase. Biochemistry 20, 2444–2449.
Eisman, B., Alonso-Monge, R., Román, E., Arana, D., Nombela, C., Pla, J., 2006. The
Cek1 and Hog1 mitogen-activated protein kinases play complementary roles in
cell wall biogenesis and chlamydospore formation in the fungal pathogen
Candida albicans. Eukaryotic Cell 5, 347–358.
Enjalbert, B., Whiteway, M., 2005. Release from quorum-sensing molecules triggers
hyphal formation during Candida albicans resumption of growth. Eukaryotic Cell
4, 1203–1210.
Enjalbert, B., Smith, D.A., Cornell, M.J., Alam, I., Nicholls, S., Brown, A.J.P., Quinn, J.,
2006. Role of the Hog1 stress-activated protein kinase in the global
transcriptional response to stress in the fungal pathogen Candida albicans.
Molecular Biology of the Cell 17, 1018–1032.
Enloe, B., Diamond, A., Mitchell, A.P., 2000. A single-transformation gene function
test in diploid Candida albicans. Journal of Bacteriology 182, 5730–5736.
Enrst, J.F., 2000. Transcription factors in Candida albicans-environmental control of
morphogenesis. Microbiology 146, 1763–1774.
Ernandes, J.R., De Meirsman, C., Rolland, F., Winderickx, J., De Winde, J., Brandão,
R.L., Thevelein, J.M., 1998. During the initiation of fermentation overexpression
of hexokinase PII in yeast transiently causes a similar deregulation of glycolysis
as deletion of Tps1. Yeast 14, 255–269.
Fairn, G.D., MacDonald, K., McMaster, C.R., 2007. A chemogenomic screen in
Saccharomyces cerevisiae uncovers a primary role for the mitochondria in
farnesol toxicity and its regulation by the Pkc1 pathway. Journal of Biological
Chemistry 282, 4868–4874.
Felix, E., 1907. Über die Bedingungen der Fuselölbildung und über ihren
Zusammenhang mit dem Eiweißaufbau der Hefe. Berichte der Deutschen
Chemischen Gesellschaft 40, 1027–1047.
Feng, Q., Summers, E., Guo, B., Fink, G., 1999. Ras signaling is required for serum-
induced hyphal differentiation in Candida albicans. Journal of Bacteriology 181,
6339–6346.
Ferna
´ndez-Arenas, E., Cabezón, V., Bermejo, C., Arroyo, J., Nombela, C., Diez-Orejas,
R., Gil, C., 2007. Integrated proteomics and genomics strategies bring new
insight into Candida albicans response upon macrophage interaction. Molecular
and Cellular Proteomics 6, 460–478.
Fradin, C., De Groot, P., MacCallum, D., Schaller, M., Klis, F., Odds, F.C., Hube, B., 2005.
Granulocytes govern the transcriptional response, morphology and
proliferation of Candida albicans in human blood. Molecular Microbiology 56,
397–415.
Fu, Y., Ibrahim, A.S., Sheppard, D.C., Chen, Y.C., French, S.W., Cutler, J.E., Filler, S.G.,
Edwards Jr., J.E., 2002. Candida albicans Als1p: an adhesin that is a downstream
effector of the EFG1 filamentation pathway. Molecular Microbiology 44, 61–72.
Fuqua, W.C., Winans, S.C., Greenberg, E.P., 1994. Quorum sensing in bacteria: the
LuxR-LuxI family of cell density-responsive transcriptional regulators. Journal
of Bacteriology 176, 269–275.
Gale, C.A., Bendel, C.M., McClellan, M., Hauser, M., Becker, J.M., Berman, J., Hostetter,
M.K., 1998. Linkage of adhesion, filamentous growth, and virulence in Candida
albicans to a single gene, INT1. Science 279, 1355–1358.
García-Sánchez, S., Aubert, S., Iraqui, I., Janbon, G., Ghigo, J.M., D’Enfert, C., 2004.
Candida albicans biofilms: a developmental state associated with specific and
stable gene expression patterns. Eukaryotic Cell 3, 536–545.
García-Sánchez, S., Mavor, A.L., Russell, C.L., Argimon, S., Dennison, P., Enjalbert, B.,
Brown, A.J.P., 2005. Global roles of Ssn6 in tup1- and nrg1-dependent gene
regulation in the fungal pathogen, Candida albicans. Molecular Biology of the
Cell 16, 2913–2925.
Ghannoum, M.A., Spellberg, B., Saporito-Irwin, S.M., Fonzi, W.A., 1995. Reduced
virulence of Candida albicans PHR1 mutants. Infection and Immunity 63, 4528–
4530.
Ghosh, S., Howe, N., Volk, K., Tati, S., Nickerson, K.W., Petro, T.M., 2010. Candida
albicans cell wall components and farnesol stimulate the expression of both
inflammatory and regulatory cytokines in the murine RAW264.7 macrophage
cell line. FEMS Immunology and Medical Microbiology 60, 63–73.
Ghosh, S., Kebaara, B.W., Atkin, A.L., Nickerson, K.W., 2008. Regulation of aromatic
alcohol production in Candida albicans. Applied and Environmental
Microbiology 74, 7211–7218.
Ghosh, S., Navarathna, D.H.M.L.P., Roberts, D.D., Cooper, J.T., Atkin, A.L., Petro, T.M.,
Nickerson, K.W., 2009. Arginine-induced germ tube formation in Candida
albicans is essential for escape from murine macrophage line RAW 264.7.
Infection and Immunity 77, 1596–1605.
Gow, N.A.R., 2009. Fungal morphogenesis: some like it hot. Current Biology 19, 621–
629.
Gow, N.A.R., Brown, A.J.P., Odds, F.C., 2002. Fungal morphogenesis and host
invasion. Current Opinion in Microbiology 5, 366–371.
Goyard, S., Knechtle, P., Chauvel, M., Mallet, A., Prevost, M.-C., Proux, C., Coppee, J.-
Y., Schwartz, P., Dromer, F., Park, H., Filler, S.G., Janbon, G., d’Enfert, C., 2008. The
Yak1 kinase is involved in the initiation and maintenance of hyphal growth in
Candida albicans. Molecular Biology of the Cell 19, 2251–2266.
Gray, K.M., Garey, J.R., 2001. The evolution of bacterial LuxI and LuxR quorum
sensing regulators. Microbiology 147, 2379–2387.
Gray, K.M., Passador, L., Iglewski, B.H., Greenberg, E.P., 1994. Interchangeability and
specificity of components from the quorum-sensing regulatory systems of
Vibrio fischeri and Pseudomonas aeruginosa. Journal of Bacteriology 176, 3076–
3080.
Grubb, S.E.W., Murdoch, C., Sudbery, P.E., Saville, S.P., Lopez-Ribot, J.L., Thornhill,
M.H., 2009. Adhesion of Candida albicans to endothelial cells under
physiological conditions of flow. Infection and Immunity 77, 3872–3878.
Hairfield, M.L., Westwater, C., Dolan, J.W., 2002. Phosphatidylinositol-4-phosphate
5-kinase activity is stimulated during temperature-induced morphogenesis in
Candida albicans. Microbiology 148, 1737–1746.
Harcus, D., Nantel, A., Marcil, A., Rigby, T., Whiteway, M., 2004. Transcription
profiling of cyclic AMP signaling in Candida albicans. Molecular Biology of the
Cell 15, 4490–4499.
Hazelwood, L.A., Daran, J.M., Van Maris, A.J.A., Pronk, J.T., Dickinson, J.R., 2008. The
Ehrlich pathway for fusel alcohol production: a century of research on
Saccharomyces cerevisiae metabolism. Applied and Environmental Microbiology
74, 2259–2266.
Henriques, M., Martins, M., Azeredo, J., Oliveira, R., 2007. Effect of farnesol on Candida
dubliniensis morphogenesis. Letters in Applied Microbiology 44, 199–205.
Hense, B.A., Kuttler, C., Müller, J., Rothballer, M., Hartmann, A., Kreft, J.U., 2007. Does
efficiency sensing unify diffusion and quorum sensing? Nature Reviews
Microbiology 5, 230–239.
Hernández, R., Nombela, C., Diez-Orejas, R., Gil, C., 2004. Two-dimensional reference
map of Candida albicans hyphal forms. Proteomics 4, 374–382.
Hilmioglu, S., Ilkit, M., Badak, Z., 2007. Comparison of 12 liquid media for germ tube
production of Candida albicans and C. tropicalis. Mycoses 50, 282–285.
Hogan, D.A., 2006a. Quorum sensing: alcohols in a social situation. Current Biology,
16.
Hogan, D.A., 2006b. Talking to themselves: autoregulation and quorum sensing in
fungi. Eukaryotic Cell 5, 613–619.
Hogan, D.A., Sundstrom, P., 2009. The Ras/cAMP/PKA signaling pathway and
virulence in Candida albicans. Future Microbiology 4, 1263–1270.
Hogan, D.A., Vik, A., Kolter, R., 2004. A Pseudomonas aeruginosa quorum-sensing
molecule influences Candida albicans morphology. Molecular Microbiology 54,
1212–1223.
Holmes, A.R., Shepherd, M.G., 1987. Proline-induced germ-tube formation in
Candida albicans: role of proline uptake and nitrogen metabolism. Journal of
General Microbiology 133, 3219–3228.
Holmes, A.R., Cannon, R.D., Shepherd, M.G., 1991. Effect of calcium ion uptake on
Candida albicans morphology. FEMS Microbiology Letters 77, 187–193.
Hornby, J.M., Kebaara, B.W., Nickerson, K.W., 2003. Farnesol biosynthesis in Candida
albicans: Cellular response to sterol inhibition by zaragozic acid B.
Antimicrobial Agents and Chemotherapy 47, 2366–2369.
Hornby, J.M., Nickerson, K.W., 2004. Enhanced production of farnesol by Candida
albicans treated with four azoles. Antimicrobial Agents and Chemotherapy 48,
2305–2307.
Hornby, J.M., Jensen, E.C., Lisec, A.D., Tasto, J.J., Jahnke, B., Shoemaker, R., Dussault,
P., Nickerson, K.W., 2001. Quorum sensing in the dimorphic fungus Candida
albicans is mediated by farnesol. Applied and Environmental Microbiology 67,
2982–2992.
Hrmova, M., Drobnica, L., 1981. Induction of mycelial type of development in
Candida albicans by low glucose concentration. Mycopathologia 76, 83–96.
760 T.-L. Han et al. / Fungal Genetics and Biology 48 (2011) 747–763
Hromatka, B.S., Noble, S.M., Johnson, A.D., 2005. Transcriptional response of Candida
albicans to nitric oxide and the role of the YHB1 gene in nitrosative stress and
virulence. Molecular Biology of the Cell 16, 4814–4826.
Hudson, D.A., Sciascia, Q.L., Sanders, R.J., Norris, G.E., Edwards, P.J.B., Sullivan, P.A.,
Farley, P.C., 2004. Identification of the dialysable serum inducer of germ-tube
formation in Candida albicans. Microbiology 150, 3041–3049.
Huh, W.K., Kim, S.T., Kim, H., Jeong, G., Kang, S.O., 2001. Deficiency of
D
-
erythroascorbic acid attenuates hyphal growth and virulence of Candida
albicans. Infection and Immunity 69, 3939–3946.
Hwang, C.S., Oh, J.H., Huh, W.K., Yim, H.S., Kang, S.O., 2003. Ssn6, an important
factor of morphological conversion and virulence in Candida albicans. Molecular
Microbiology 47, 1029–1043.
Johnson, D.I., 1999. Cdc42: an essential Rho-type GTPase controlling eukaryotic cell
polarity. Microbiology and Molecular Biology Reviews 63, 54–105.
José, C.S., Monge, R.A., Pérez-Díaz, R., Pla, J., Nombela, C., 1996. The mitogen-activated
protein kinase homolog HOG1 gene controls glycerol accumulation in the
pathogenic fungus Candida albicans. Journal of Bacteriology 178, 5850–5852.
Kadosh, D., Johnson, A.D., 2001. Rfg1, a protein related to the Saccharomyces
cerevisiae hypoxic regulator Rox1, controls filamentous growth and virulence in
Candida albicans. Molecular and Cellular Biology 21, 2496–2505.
Karababa, M., Coste, A.T., Rognon, B., Bille, J., Sanglard, D., 2004. Comparison of gene
expression profiles of Candida albicans azole-resistant clinical isolates and
laboratory strains exposed to drugs inducing multidrug transporters.
Antimicrobial Agents and Chemotherapy 48, 3064–3079.
Kebaara, B.W., Langford, M.L., Navarathna, D.H.M.L.P., Dumitru, R., Nickerson, K.W.,
Atkin, A.L., 2008. Candida albicans Tup1 is involved in farnesol-mediated
inhibition of filamentous-growth induction. Eukaryotic Cell 7, 980–987.
Khalaf, R.A., Zitomer, R.S., 2001. The DNA binding protein Rfg1 is a repressor of
filamentation in Candida albicans. Genetics 157, 1503–1512.
Klengel, T., Liang, W.-J., Chaloupka, J., Ruoff, C., Schröpel, K., Naglik, J.R., Eckert, S.E.,
Mogensen, E.G., Haynes, K., Tuite, M.F., Levin, L.R., Buck, J., Mülschlegel, F.A.,
2005. Fungal adenylyl cyclase integrates CO
2
sensing with cAMP signaling and
virulence. Current Biology 15, 2021–2026.
Kruppa, M., Krom, B.P., Chauhan, N., Bambach, A.V., Cihlar, R.L., Calderone, R.A.,
2004. The two-component signal transduction protein Chk1p regulates quorum
sensing in Candida albicans. Eukaryotic Cell 3, 1062–1065.
Kügler, S., Sebghati, T.S., Eissenberg, L.G., Goldman, W.E., 2000. Phenotypic variation
and intracellular parasitism by Histoplasma capsulatum. Proceedings of the
National Academy of Sciences of the United States of America 97, 8794–8798.
Kusch, H., Engelmann, S., Bode, R., Albrecht, D., Morschhäuser, J., Hecker, M., 2008. A
proteomic view of Candida albicans yeast cell metabolism in exponential and
stationary growth phases. International Journal of Medical Microbiology 298,
291–318.
Lan, C.Y., Rodarte, G., Murillo, L.A., Jones, T., Davis, R.W., Dungan, J., Newport, G.,
Agabian, N., 2004. Regulatory networks affected by iron availability in Candida
albicans. Molecular Microbiology 53, 1451–1469.
Lane, S., Birse, C., Zhou, S., Matson, R., Liu, H., 2001. DNA array studies demonstrate
convergent regulation of virulence factors by Cph1, Cph2, and Efg1 in Candida
albicans. Journal of Biological Chemistry 276, 48988–48996.
Langford, M.L., Hasim, S., Nickerson, K.W., Atkin, A.L., 2010. Activity and toxicity of
farnesol towards Candida albicans are dependent on growth conditions.
Antimicrobial Agents and Chemotherapy 54, 940–942.
Lazo, Chapa Y., Bates, S., Sudbery, P., 2005. The G1 cyclin Cln3 regulates
morphogenesis in Candida albicans. Eukaryotic Cell 4, 90–94.
Leberer, E., Harcus, D., Broadbent, I.D., Clark, K.L., Dignard, D., Ziegelbauer, K.,
Schmidt, A., Gow, N.A.R., Brown, A.J.P., Thomas, D.Y., 1996. Signal transduction
through homologs of the Ste20p and Ste7p protein kinases can trigger hyphal
formation in the pathogenic fungus Candida albicans. Proceedings of the
National Academy of Sciences of the United States of America 93, 13217–13222.
Leberer, E., Harcus, D., Dignard, D., Johnson, L., Ushinsky, S., Thomas, D.Y., Schröppel,
K., 2001. Ras links cellular morphogenesis to virulence by regulation of the MAP
kinase and cAMP signalling pathways in the pathogenic fungus Candida
albicans. Molecular Microbiology 42, 673–687.
Lee, H., Mitchell, D.R.S., 1979. Commitment to germ tube or bud formation during
release from stationary phase in Candida albicans. Experimental Cell Research
120, 167–179.
Lee, K.L., Buckley, H.R., Campbell, C.C., 1975. An amino acid liquid synthetic medium
for the development of mycelial and yeast forms of Candida albicans.
Sabouraudia Journal of Medical and Veterinary Mycology 13, 148–153.
Lee, K.H., Shin, W.S., Kim, D., Koh, C.M., 1999. The presumptive identification of
Candida albicans with germ tube induced by high temperature. Yonsei Medical
Journal 40, 420–424.
Leng, P., Lee, P.R., Wu, H., Brown, A.J.P., 2001. Efg1, a morphogenetic regulator in
Candida albicans, is a sequence-specific DNA binding protein. Journal of
Bacteriology 183, 4090–4093.
Lengeler, K.B., Davidson, R.C., D’Souza, C., Harashima, T., Shen, W.C., Wang, P., Pan,
X., Waugh, M., Heitman, J., 2000. Signal transduction cascades regulating fungal
development and virulence. Microbiology and Molecular Biology Reviews 64,
746–785.
Leroy, O., Gangneux, J.P., Montravers, P., Mira, J.P., Gouin, F., Sollet, J.P., Carlet, J.,
Reynes, J., Rosenheim, M., Regnier, B., Lortholary, O., 2009. Epidemiology,
management, and risk factors for death of invasive Candida infections in critical
care: a multicenter, prospective, observational study in France (2005–2006).
Critical Care Medicine 37, 1612–1618.
Li, W., Mitchell, A.P., 1997. Proteolytic activation of rim1p, a positive regulator of
yeast sporulation and invasive growth. Genetics 145, 63–73.
Licciardello, G., Bertani, I., Steindler, L., Bella, P., Venturi, V., Catara, V., 2007.
Pseudomonas corrugata contains a conserved N-acyl homoserine lactone
quorum sensing system; its role in tomato pathogenicity and tobacco
hypersensitivity response. FEMS Microbiology Ecology 61, 222–234.
Lingappa, B.T., Prasad, M., Lingappa, Y., Hunt, D.F., Biemann, K., 1969. Phenethyl
alcohol and tryptophol: autoantibiotics produced by the fungus Candida
albicans. Science 163, 192–194.
Liu, H., 2001. Transcriptional control of dimorphism in Candida albicans. Current
Opinion in Microbiology 4, 728–735.
Liu, H., 2002. Co-regulation of pathogenesis with dimorphism and phenotypic
switching in Candida albicans, a commensal and a pathogen. International
Journal of Medical Microbiology 292, 299–311.
Liu, H., Kohler, J., Fink, G.R., 1994. Suppression of hyphal formation in Candida
albicans by mutation of a STE12 homolog. Science 266, 1723–1726.
Liu, P., Deng, B., Long, C.A., Min, X., 2009. Effect of farnesol on morphogenesis in the
fungal pathogen Penicillium expansum. Annals of Microbiology 59, 33–38.
Lo, H.J., Köhler, J.R., Didomenico, B., Loebenberg, D., Cacciapuoti, A., Fink, G.R., 1997.
Nonfilamentous C. albicans mutants are avirulent. Cell 90, 939–949.
Loeb, J.D.J., Sepulveda-Becerra, M., Hazan, I., Liu, H., 1999. A G1 cyclin is necessary
for maintenance of filamentous growth in Candida albicans. Molecular and
Cellular Biology 19, 4019–4027.
Lorenz, M.C., Fink, G.R., 2001. The glyoxylate cycle is required for fungal virulence.
Nature 412, 83–86.
Lorenz, M.C., Bender, J.A., Fink, G.R., 2004. Transcriptional response of Candida
albicans upon internalization by macrophages. Eukaryotic Cell 3, 1076–1087.
Maidan, M.M., De Rop, L., Serneels, J., Exler, S., Rupp, S., Tournu, H., Thevelein, J.M.,
Van Dijck, P., 2005a. The G protein-coupled receptor Gpr1 and the G
a
protein
Gpa2 act through the cAMP-protein kinase A pathway to induce morphogenesis
in Candida albicans. Molecular Biology of the Cell 16, 1971–1986.
Maidan, M.M., Thevelein, J.M., Van Dijck, P., 2005b. Carbon source induced yeast-to-
hypha transition in Candida albicans is dependent on the presence of amino
acids and on the G-protein-coupled receptor Gpr1. Biochemical Society
Transactions 33, 291–293.
Martins, L.F., Montero-Lomeli, M., Masuda, C.A., Fortes, F.S.A., Previato, J.O.,
Mendonça-Previato, L., 2008. Lithium-mediated suppression of morphogenesis
and growth in Candida albicans. FEMS Yeast Research 8, 615–621.
Mavor, A.L., Thewes, S., Hube, B., 2005. Systemic fungal infections caused by Candida
species: epidemiology, infection process and virulence attributes. Current Drug
Targets 6, 863–874.
Menon, V., Li, D., Chauhan, N., Rajnarayanan, R., Dubrovska, A., West, A.H.,
Calderone, R., 2006. Functional studies of the Ssk1p response regulator
protein of Candida albicans as determined by phenotypic analysis of receiver
domain point mutants. Molecular Microbiology 62, 997–1013.
Mitchell, A.P., 1998. Dimorphism and virulence in Candida albicans. Current Opinion
in Microbiology 1, 687–692.
Mock, R.C., Pollack, J.H., Hashimoto, T., 1990. Carbon dioxide induces endotrophic
germ tube formation in Candida albicans. Canadian Journal of Microbiology 36,
249–253.
Moran, C., Grussemeyer, C.A., Spalding, J.R., Benjamin Jr., D.K., Reed, S.D., 2010.
Comparison of costs, length of stay, and mortality associated with Candida
glabrata and Candida albicans bloodstream infections. American Journal of
Infection Control 38, 78–80.
Mosel, D.D., Dumitru, R., Hornby, J.M., Atkin, A.L., Nickerson, K.W., 2005. Farnesol
concentrations required to block germ tube formation in Candida albicans in the
presence and absence of serum. Applied and Environmental Microbiology 71,
4938–4940.
Mühlschlegel, F.A., Fonzi, W.A., 1997. PHR2 of Candida albicans encodes a functional
homolog of the pH-regulated gene PHR1 with an inverted pattern of pH-
dependent expression. Molecular and Cellular Biology 17, 5960–5967.
Murad, A.M.A., D’Enfert, C., Gaillardin, C., Tournu, H., Tekaia, F., Talibi, D., Marechal,
D., Marchais, V., Cottin, J., Brown, A.J.P., 2001. Transcript profiling in Candida
albicans reveals new cellular functions for the transcriptional repressors
CaTup1, CaMig1 and CaNrg1. Molecular Microbiology 42, 981–993.
Nagahashi, S., Mio, T., Ono, N., Yamada-Okabe, T., Arisawa, M., Bussey, H., Yamada-
Okabe, H., 1998. Isolation of CaSLN1 and CaNIK1, the genes for osmosensing
histidine kinase homologues, from the pathogenic fungus Candida albicans.
Microbiology 144, 425–432.
Nantel, A., Dignard, D., Bachewich, C., Harcus, D., Marcil, A., Bouin, A.P., Sensen, C.W.,
Hogues, H., Van het Hoog, M., Gordon, P., Rigby, T., Benoit, F., Tessier, D.C.,
Thomas, D.Y., Whiteway, M., 2002. Transcription profiling of Candida albicans
cells undergoing the yeast-to-hyphal transition. Molecular Biology of the Cell
13, 3452–3465.
Navarathna, D.H.M.L.P., Hornby, J.M., Hoerrmann, N., Parkhurst, A.M., Duhamel, G.E.,
Nickerson, K.W., 2005. Enhanced pathogenicity of Candida albicans pre-treated
with subinhibitory concentrations of fluconazole in a mouse model of
disseminated candidiasis. Journal of Antimicrobial Chemotherapy 56, 1156–
1159.
Navarro-García, F., Alonso-Monge, R., Rico, H., Pla, J., Sentandreu, R., Nombela, C.,
1998. A role for the MAP kinase gene MKC1 in cell wall construction and
morphological transitions in Candida albicans. Microbiology 144, 411–424.
Navarro-García, F., Sánchez, M., Nombela, C., Pla, J., 2001. Virulence genes in the
pathogenic yeast Candida albicans. FEMS Microbiology Reviews 25, 245–268.
Nealson, K.H., 1977. Autoinduction of bacterial luciferase. Occurrence, mechanism
and significance. Archives of Microbiology 112, 73–79.
Nemecek, J.C., Wüthrich, M., Klein, B.S., 2006. Global control of dimorphism and
virulence in fungi. Science 312, 583–588.
T.-L. Han et al. / Fungal Genetics and Biology 48 (2011) 747–763 761
Nett, J.E., Lepak, A.J., Marchillo, K., Andes, D.R., 2009. Time course global gene
expression analysis of an in vivo Candida biofilm. Journal of Infectious Diseases
200, 307–313.
Nickerson, K.W., Atkin, A.L., Hornby, J.M., 2006. Quorum sensing in dimorphic fungi:
farnesol and beyond. Applied and Environmental Microbiology 72, 3805–3813.
Niimi, M., Niimi, K., Tokunaga, J., Nakayama, H., 1980. Changes in cyclic nucleotide
levels and dimorphic transition in Candida albicans. Journal of Bacteriology 142,
1010–1014.
Nobile, C.J., Solis, N., Myers, C.L., Fay, A.J., Deneault, J.S., Nantel, A., Mitchell, A.P.,
Filler, S.G., 2008. Candida albicans transcription factor Rim101 mediates
pathogenic interactions through cell wall functions. Cellular Microbiology 10,
2180–2196.
Odds, F.C., 1988. Candida and Candidosis: A Review and Bibiography, London.
Oh, K.B., Miyazawa, H., Naito, T., Matsuoka, H., 2001. Purification and
characterization of an autoregulatory substance capable of regulating the
morphological transition in Candida albicans. Proceedings of the National
Academy of Sciences of the United States of America 98, 4664–4668.
Padovan, A.C.B., Chaves, G.M., Colombo, A.L., Briones, M.R.S., 2009. A novel allele of
HWP1, isolated from a clinical strain of Candida albicans with defective hyphal
growth and biofilm formation, has deletions of Gln/Pro and Ser/Thr repeats
involved in cellular adhesion. Medical Mycology 47, 824–835.
Payne, W.E., Kaiser, C.A., Bevis, B.J., Soderholm, J., Fu, D., Sears, I.B., Glick, B.S., 2000.
Identification of YPDI, a gene of Candida albicans which encodes a two-
component phosphohistidine intermediate protein. Yeast 16, 1053–1059.
Pedreño, Y., Maicas, S., Argüelles, J.C., Sentandreu, R., Valentin, E., 2004. The ATC1
gene encodes a cell wall-linked acid trehalase required for growth on trehalose
in Candida albicans. Journal of Biological Chemistry 279, 40852–40860.
Pedreño, Y., González-Párraga, P., Martínez-Esparza, M., Sentandreu, R., Valentín, E.,
Argüelles, J.C., 2007. Disruption of the Candida albicans ATC1 gene encoding a
cell-linked acid trehalase decreases hypha formation and infectivity without
affecting resistance to oxidative stress. Microbiology 153, 1372–1381.
Pfaller, M.A., Diekema, D.J., 2007. Epidemiology of invasive candidiasis: a persistent
public health problem. Clinical Microbiology Reviews 20, 133–163.
Piekarska, K., Mol, E., Van Den Berg, M., Hardy, G., Van Den Burg, J., Van Roermund,
C., MacCallum, D., Odds, F., Distel, B., 2006. Peroxisomal fatty acid Î
2
-oxidation is
not essential for virulence of Candida albicans. Eukaryotic Cell 5, 1847–1856.
Piper, K.R., Beck Von Bodman, S., Farrand, S.K., 1993. Conjugation factor of
Agrobacterium tumefaciens regulates Ti plasmid transfer by autoinduction.
Nature 362, 448–450.
Pitarch, A., Abian, J., Carrascal, M., Sánchez, M., Nombela, C., Gil, C., 2004.
Proteomics-based identification of novel Candida albicans antigens for
diagnosis of systemic candidiasis in patients with underlying hematological
malignancies. Proteomics 4, 3084–3106.
Pollack, J.H., Hashimoto, T., 1987. The role of glucose in the pH regulation of germ-
tube formation in Candida albicans. Journal of General Microbiology 133, 415–
424.
Ramage, G., Saville, S.P., Wickes, B.L., López-Ribot, J.L., 2002. Inhibition of Candida
albicans biofilm formation by farnesol, a quorum-sensing molecule. Applied and
Environmental Microbiology 68, 5459–5463.
Ramírez, M.A., Lorenz, M.C., 2007. Mutations in alternative carbon utilization
pathways in Candida albicans attenuate virulence and confer pleiotropic
phenotypes. Eukaryotic Cell 6, 280–290.
Ramon, A.M., Porta, A., Fonzi, W.A., 1999. Effect of environmental pH on
morphological development of Candida albicans is mediated via the PacC-
related transcription factor encoded by PRR2. Journal of Bacteriology 181,
7524–7530.
Rao, G.R., Sirsi, M., Ramakrishnan, T., 1962. Enzymes in Candida albicans. II.
Tricarboxylic acid cycle and related enzymes. Journal of Bacteriology 84, 778–
783.
Reynolds, R., Braude, A.I., 1956. The filament inducing property of blood for Candida
albicans; its nature and significance. Clinical Research Procedure 4, 40.
Rocha, C.R.C., Schröppel, K., Harcus, D., Marcil, A., Dignard, D., Taylor, B.N., Thomas,
D.Y., Whiteway, M., Leberer, E., 2001. Signaling through adenylyl cyclase is
essential for hyphal growth and virulence in the pathogenic fungus Candida
albicans. Molecular Biology of the Cell 12, 3631–3643.
Rodaki, A., Bohovych, I.M., Enjalbert, B., Young, T., Odds, F.C., Gow, N.A.R., Brown,
A.J.P., 2009. Glucose promotes stress resistance in the fungal pathogen Candida
albicans. Molecular Biology of the Cell 20, 4845–4855.
Rogers, P.D., Barker, K.S., 2002. Evaluation of differential gene expression in
fluconazole-susceptible and -resistant isolates of Candida albicans by cDNA
microarray analysis. Antimicrobial Agents and Chemotherapy 46, 3412–3417.
Roma
´n, E., Nombela, C., Pla, J., 2005. The Sho1 adaptor protein links oxidative stress
to morphogenesis and cell wall biosynthesis in the fungal pathogen Candida
albicans. Molecular and Cellular Biology 25, 10611–10627.
Román, E., Arana, D.M., Nombela, C., Alonso-Monge, R., Pla, J., 2007. MAP kinase
pathways as regulators of fungal virulence. Trends in Microbiology 15, 181–
190.
Román, E., Alonso-Monge, R., Gong, Q., Li, D., Calderone, R., Pla, J., 2009. The Cek1
MAPK is a short-lived protein regulated by quorum sensing in the fungal
pathogen Candida albicans. FEMS Yeast Research 9, 942–955.
Rooney, P.J., Klein, B.S., 2002. Linking fungal morphogenesis with virulence. Cellular
Microbiology 4, 127–137.
Rosenberg, E., Keller, K.H., Dworkin, M., 1977. Cell density dependent growth of
Myxococcus xanthus on casein. Journal of Bacteriology 129, 770–777.
Rubin-Bejerano, I., Fraser, I., Grisafi, P., Fink, G.R., 2003. Phagocytosis by neutrophils
induces an amino acid deprivation response in Saccharomyces cerevisiae and
Candida albicans. Proceedings of the National Academy of Sciences of the United
States of America 100, 11007–11012.
Sabie, F.T., Gadd, G.M., 1989. Involvement of a Ca
2+
-calmodulin interaction in the
yeast-mycelial (Y-M) transition of Candida albicans. Mycopathologia 108, 47–
54.
Sa
´nchez-Marti
´nez, C., Pe
´rez-Marti
´n, J., 2002. Gpa2, a G-protein subunit required for
hyphal development in Candida albicans. Eukaryotic Cell 1, 865–874.
Sato, T., Watanabe, T., Mikami, T., Matsumoto, T., 2004. Farnesol, a morphogenetic
autoregulatory substance in the dimorphic fungus Candida albicans, inhibits
hyphae growth through suppression of a mitogen-activated protein kinase
cascade. Biological and Pharmaceutical Bulletin 27, 751–752.
Saville, S.P., Lazzell, A.L., Monteagudo, C., Lopez-Ribot, J.L., 2003. Engineered control
of cell morphology in vivo reveals distinct roles for yeast and filamentous forms
of Candida albicans during infection. Eukaryotic Cell 2, 1053–1060.
Schaefer, A.L., Val, D.L., Hanzelka, B.L., Cronan Jr., J.E., Greenberg, E.P., 1996.
Generation of cell-to-cell signals in quorum sensing: acyl homoserine lactone
synthase activity of a purified Vibrio fischeri LuxI protein. Proceedings of the
National Academy of Sciences of the United States of America 93, 9505–9509.
Scheper, M.A., Shirtliff, M.E., Meiller, T.F., Peters, B.M., Jabra-Rizk, M.A., 2008.
Farnesol, a fungal quorum-sensing molecule triggers apoptosis in human oral
squamous carcinoma cells. Neoplasia 10, 954–963.
Schwartz, D.S., Larsh, H.W., 1982. Comparative activities of glycolytic enzymes in
yeast and mycelial forms of Candida albicans. Mycopathologia 78, 93–98.
Schweizer, A., Rupp, S., Taylor, B.N., Röllinghoff, M., Schröppel, K., 2000. The TEA/
ATTS transcription factor CaTec1p regulates hyphal development and virulence
in Candida albicans. Molecular Microbiology 38, 435–445.
Semighini, C.P., Hornby, J.M., Dumitru, R., Nickerson, K.W., Harris, S.D., 2006.
Farnesol-induced apoptosis in Aspergillus nidulans reveals a possible mechanism
for antagonistic interactions between fungi. Molecular Microbiology 59, 753–
764.
Sentheshanmuganathan, S., 1960. The mechanism of the formation of higher
alcohols from amino acids by Saccharomyces cerevisiae. Biochemical Journal 47,
558–576.
Sexton, J.A., Brown, V., Johnston, M., 2007. Regulation of sugar transport and
metabolism by the Candida albicans Rgt1 transcriptional repressor. Yeast 24,
847–860.
Shank, E.A., Kolter, R., 2009. New developments in microbial interspecies signaling.
Current Opinion in Microbiology 12, 205–214.
Sharkey, L.L., McNemar, M.D., Saporito-Irwin, S.M., Sypherd, P.S., Fonzi, W.A., 1999.
HWP1 functions in the morphological development of Candida albicans
downstream of EFG1, TUP1, and RBF1. Journal of Bacteriology 181, 5273–5279.
Shchepin, R., Hornby, J.M., Burger, E., Niessen, T., Dussault, P., Nickerson, K.W., 2003.
Quorum sensing in Candida albicans: probing farnesol’s mode of action with 40
natural and synthetic farnesol analogs. Chemistry and Biology 10, 743–750.
Shi, Q.M., Wang, Y.M., Zheng, X.D., Lee, R.T.H., Wang, Y., 2007. Critical role of DNA
checkpoints in mediating genotoxic-stress-induced filamentous growth in
Candida albicans. Molecular Biology of the Cell 18, 815–826.
Shirtliff, M.E., Krom, B.P., Meijering, R.A.M., Peters, B.M., Zhu, J., Scheper, M.A.,
Harris, M.L., Jabra-Rizk, M.A., 2009. Farnesol-induced apoptosis in Candida
albicans. Antimicrobial Agents and Chemotherapy 53, 2392–2401.
Sims, W., 1986. Effect of carbon dioxide on the growth and form of Candida albicans.
Journal of Medical Microbiology 22, 203–208.
Singh, V., Sinha, I., Sadhale, P.P., 2005. Global analysis of altered gene expression
during morphogenesis of Candida albicans in vitro. Biochemical and Biophysical
Research Communications 334, 1149–1158.
Singh, V., Satheesh, S.V., Raghavendra, M.L., Sadhale, P.P., 2007. The key enzyme in
galactose metabolism, UDP-galactose-4-epimerase, affects cell-wall integrity
and morphology in Candida albicans even in the absence of galactose. Fungal
Genetics and Biology 44, 563–574.
Sinha, I., Wang, Y.M., Philp, R., Li, C.R., Yap, W.H., Wang, Y., 2007. Cyclin-dependent
kinases control septin phosphorylation in Candida albicans hyphal development.
Developmental Cell 13, 421–432.
Smail, E.H., Cronstein, B.N., Meshulam, T., Esposito, A.L., Ruggeri, R.W., Diamond,
R.D., 1992. In vitro, Candida albicans releases the immune modulator adenosine
and a second, high-molecular weight agent that blocks neutrophil killing.
Journal of Immunology 148, 3588–3595.
Smith, D.A., Nicholls, S., Morgan, B.A., Brown, A.J.P., Quinn, J., 2004. A conserved
stress-activated protein kinase regulates a core stress response in the human
pathogen Candida albicans. Molecular Biology of the Cell 15, 4179–4190.
Stoldt, V.R., Sonneborn, A., Leuker, C.E., Ernst, J.F., 1997. Efg1p, an essential regulator
of morphogenesis of the human pathogen Candida albicans, is a member of a
conserved class of bHLH proteins regulating morphogenetic processes in fungi.
EMBO Journal 16, 1982–1991.
Strich, R., Surosky, R.T., Steber, C., Dubois, E., Messenguy, F., Esposito, R.E., 1994.
UME6 is a key regulator of nitrogen repression and meiotic development. Genes
and Development 8, 796–810.
Strijbis, K., Van Roermund, C.W.T., Hardy, G.P., Van Den Burg, J., Bloem, K., De Haan,
J., Van Vlies, N., Wanders, R.J.A., Vaz, F.M., Distel, B., 2009. Identification and
characterization of a complete carnitine biosynthesis pathway in Candida
albicans. FASEB Journal 23, 2349–2359.
Su, Z., Osborne, M.J., Xu, P., Xu, X., Li, Y., Ni, F., 2005. A bivalent dissectional analysis
of the high-affinity interactions between Cdc42 and the Cdc42/Rac interactive
binding domains of signaling kinases in Candida albicans. Biochemistry 44,
16461–16474.
Sudbery, P., Gow, N., Berman, J., 2004. The distinct morphogenic states of Candida
albicans. Trends in Microbiology 12, 317–324.
762 T.-L. Han et al. / Fungal Genetics and Biology 48 (2011) 747–763
Sullivan, P.A., Shepherd, M.G., 1982. Gratuitous induction by N-acetylmannosamine
of germ tube formation and enzymes for N-acetylglucosamine utilization in
Candida albicans. Journal of Bacteriology 151, 1118–1122.
Sun, J., Zeng, A.P., 2004. IdentiCS – indentification of coding sequence and in silico
reconstruction of the metabolic network directly from unannotated low-
coverage bacterial genome sequence. BMC Bioinformatics 5.
Swindell, K., Lattif, A.A., Chandra, J., Mukherjee, P.K., Ghannoum, M.A., 2009.
Parenteral lipid emulsion induces germination of Candida albicans and increases
biofilm formation on medical catheter surfaces. Journal of Infectious Diseases
200, 473–480.
Swoboda, R.K., Bertram, G., Delbrück, S., Ernst, J.F., Gow, N.A.R., Gooday, G.W.,
Brown, A.J.P., 1994. Fluctuations in glycolytic mRNA levels during
morphogenesis in Candida albicans reflect underlying changes in growth and
are not a response to cellular dimorphism. Molecular Microbiology 13, 663–
672.
Tarry, W., Fisher, M., Shen, S., Mawhinney, M., 2005. Candida albicans: the estrogen
target for vaginal colonization. Journal of Surgical Research 129, 278–282.
Thomas, D.P., Viudes, A., Monteagudo, C., Lazzell, A.L., Saville, S.P., López-Ribot, J.L.,
2006. A proteomic-based approach for the identification of Candida albicans
protein components present in a subunit vaccine that protects against
disseminated candidiasis. Proteomics 6, 6033–6041.
Timpel, C., Strahl-Bolsinger, S., Ziegelbauer, K., Ernst, J.F., 1998. Multiple functions of
Pmt1p-mediated protein O-mannosylation in the fungal pathogen Candida
albicans. Journal of Biological Chemistry 273, 20837–20846.
Timpel, C., Zink, S., Strahl-Bolsinger, S., Schröppel, K., Ernst, J., 2000. Morphogenesis,
adhesive properties, and antifungal resistance depend on the Pmt6 protein
mannosyltransferase in the fungal pathogen Candida albicans. Journal of
Bacteriology 182, 3063–3071.
Toenjes, K.A., Munsee, S.M., Ibrahim, A.S., Jeffrey, R., Edwards Jr., J.E., Johnson, D.I.,
2005. Small-molecule inhibitors of the budded-to-hyphal-form transition in the
pathogenic yeast Candida albicans. Antimicrobial Agents and Chemotherapy 49,
963–972.
Tournu, H., Tripathi, G., Bertram, G., Macaskill, S., Mavor, A., Walker, L., Odds, F.C.,
Gow, N.A.R., Brown, A.J.P., 2005. Global role of the protein kinase Gcn2 in the
human pathogen Candida albicans. Eukaryotic Cell 4, 1687–1696.
Tripathi, G., Wiltshire, C., Macaskill, S., Tournu, H., Budge, S., Brown, A.J.P., 2002.
Gcn4 co-ordinates morphogenetic and metabolic responses to amino acid
starvation in Candida albicans. EMBO Journal 21, 5448–5456.
Trunk, K., Gendron, P., Nantel, A., Lemieux, S., Roemer, T., Raymond, M., 2009.
Depletion of the cullin Cdc53p induces morphogenetic changes in Candida
albicans. Eukaryotic Cell 8, 756–767.
Tsao, C.C., Chen, Y.T., Lan, C.Y., 2009. A small G protein Rhb1 and a GTPase-activating
protein Tsc2 involved in nitrogen starvation-induced morphogenesis and cell
wall integrity of Candida albicans. Fungal Genetics and Biology 46, 126–136.
Urban, C., Sohn, K., Lottspeich, F., Brunner, H., Rupp, S., 2003. Identification of cell
surface determinants in Candida albicans reveals Tsa1p, a protein differentially
localized in the cell. FEBS Letters 544, 228–235.
Vellucci, V.F., Gygax, S.E., Hostetter, M.K., 2007. Involvement of Candida albicans
pyruvate dehydrogenase complex protein X (Pdx1) in filamentation. Fungal
Genetics and Biology 44, 979–990.
Vidotto, V., Accattatis, G., Zhang, Q., Campanini, G., Aoki, S., 1996a. Glucose
influence on germ tube production in Candida albicans. Mycopathologia 133,
143–147.
Vidotto, V., Sinicco, A., Accattatis, G., Aoki, S., 1996b. Influence of fructose on
Candida albicans germ tube production. Mycopathologia 135, 85–88.
Villas-Bôas, S.G., Roessner, U., Hansen, M.A.E., Smedsfaard, J., Nielsen, J., 2007.
Metabolome Analysis: An Introduction. Wiley-Interscience, New Jersey.
Wang, Y., 2009. CDKs and the yeast-hyphal decision. Current Opinion in
Microbiology 12, 1–6.
Wang, A., Raniga, P.P., Lane, S., Lu, Y., Liu, H., 2009. Hyphal chain formation in
Candida albicans: Cdc28-Hgc1 phosphorylation of Efg1 represses cell separation
genes. Molecular and Cellular Biology 29, 4406–4416.
Warenda, A.J., Kauffman, S., Sherrill, T.P., Becker, J.M., Konopka, J.B., 2003. Candida
albicans septin mutants are defective for invasive growth and virulence.
Infection and Immunity 71, 4045–4051.
Westwater, C., Balish, E., Schofield, D.A., 2005. Candida albicans-conditioned
medium protects yeast cells from oxidative stress: a possible link between
quorum sensing and oxidative stress resistance. Eukaryotic Cell 4, 1654–1661.
White, S., Larsen, B., 1997. Candida albicans morphogenesis is influenced by estogen.
Cellular and Molecular Life Sciences 53, 744–749.
Whiteway, M., Bachewich, C., 2007. Morphogenesis in Candida albicans. Annual
Review of Microbiology 61, 529–553.
Wingard, J.R., Merz, W.G., Saral, R., 1979. Candida tropicalis: a major pathogen in
immunocompromised patients. Annals of Internal Medicine 91, 539–543.
Wisplinghoff, H., Bischoff, T., Tallent, S.M., Seifert, H., Wenzel, R.P., Edmond, M.B.,
2004. Erratum: nosocomial bloodstream infections in US hospitals: analysis of 24,
179 cases from a prospective nationwide surveillance study (Clinical Infectious
Diseases (August 1, 2004) 39 (309–317)). Clinical Infectious Diseases 39, 1093.
Xu, X.-L., Lee, R.T.H., Fang, H.-M., Wang, Y.-M., Li, R., Zou, H., Zhu, Y., Wang, Y., 2008.
Bacterial peptidoglycan triggers Candida albicans hyphal growth by directly
activating the adenylyl cyclase Cyr1p. Cell Host & Microbe 4, 28–39.
Yamada-Okabe, T., Mio, T., Ono, N., Kashima, Y., Matsui, M., Arisawa, M., Yamada-
Okabe, H., 1999. Roles of three histidine kinase genes in hyphal development
and virulence of the pathogenic fungus Candida albicans. Journal of Bacteriology
181, 7243–7247.
Yin, Z., Stead, D., Selway, L., Walker, J., Riba-Garcia, I., McInerney, T., Gaskell, S., Oliver,
S.G., Cash, P., Brown, A.J.P., 2004. Proteomic response to amino acid starvation in
Candida albicans and Saccharomyces cerevisiae. Proteomics 4, 2425–2436.
Zaragoza, O., Blazquez, M.A., Gancedo, C., 1998. Disruption of the Candida albicans
TPS1 gene encoding trehalose-6-phosphate synthase impairs formation of
hyphae and decreases infectivity. Journal of Bacteriology 180, 3809–3815.
Zheng, X., Wang, Y., 2004. Hgc1, a novel hypha-specific G1 cyclin-related protein
regulates Candida albicans hyphal morphogenesis. EMBO Journal 23, 1845–
1856.
Zhou, H., Lorenz, M.C., 2008. Carnitine acetyltransferases are required for growth on
non-fermentable carbon sources but not for pathogenesis in Candida albicans.
Microbiology 154, 500–509.
Zibafar, E., Hashemi, S.J., Zaini, F., Zeraati, H., Rezaie, S., Kordbacheh, P., 2009.
Inhibitory effect of farnesol on biofilm formation by Candida tropicalis. Daru 17,
19–23.
T.-L. Han et al. / Fungal Genetics and Biology 48 (2011) 747–763 763
... GDH3 (NADPH-dependent glutamate dehydrogenase). This group of genes is collectively essential for nitrogen metabolism, the maintenance of the redox balance, and C. albicans filament formation [47,48]. For example, GPD1 and GPD2 (two isoforms of glycerol 3-phosphate dehydrogenase) are ratecontrolling enzymes in essential glycerol formation reactions in Saccharomyces cerevisiae [49]. ...
... For example, GPD1 and GPD2 (two isoforms of glycerol 3-phosphate dehydrogenase) are ratecontrolling enzymes in essential glycerol formation reactions in Saccharomyces cerevisiae [49]. They also play a crucial role in osmoregulation, carbohydrate metabolism, and redox balancing [47,50]. It is worth noting that both Gpd1 and Gpd2 are negatively regulated by the phosphorylation activity of the AMP-activated protein kinase Snf1, the TORC2-dependent kinases Ypk1 and Ypk2 possibly in a Ppg1-dependant manner [51]. ...
... INO1 (Inositol-1-phosphate synthase), which is vital for inositol synthesis, is considered as a growth factor that supports the formation of glycophosphatidylinositol (GPI)-anchored glycolipids on Candida cell surface and hence the promotion of pathogenesis [55,56]. AAH1 (an Adenine deaminase) is similar to serine/threonine dehydratases essential for purine salvage and nitrogen catabolism [47]. MET14 (an adenylylsulfate kinase) is essential for assimilating sulfate to sulfide, which strongly depends on yeast growth conditions such as glucose [57]. ...
Article
Full-text available
Candida albicans is the leading cause of life-threatening bloodstream candidiasis, especially among immunocompromised patients. The reversible morphological transition from yeast to hyphal filaments in response to host environmental cues facilitates C . albicans tissue invasion, immune evasion, and dissemination. Hence, it is widely considered that filamentation represents one of the major virulence properties in C . albicans . We have previously characterized Ppg1, a PP2A-type protein phosphatase that controls filament extension and virulence in C . albicans . This study conducted RNA sequencing analysis of samples obtained from C . albicans wild type and ppg1 Δ / Δ strains grown under filament-inducing conditions. Overall, ppg1 Δ / Δ strain showed 1448 upregulated and 710 downregulated genes, representing approximately one-third of the entire annotated C . albicans genome. Transcriptomic analysis identified significant downregulation of well-characterized genes linked to filamentation and virulence, such as ALS3 , HWP1 , ECE1 , and RBT1 . Expression analysis showed that essential genes involved in C . albicans central carbon metabolisms, including GDH3 , GPD1 , GPD2 , RHR2 , INO1 , AAH1 , and MET14 were among the top upregulated genes. Subsequent metabolomics analysis of C . albicans ppg1 Δ / Δ strain revealed a negative enrichment of metabolites with carboxylic acid substituents and a positive enrichment of metabolites with pyranose substituents. Altogether, Ppg1 in vitro analysis revealed a link between metabolites substituents and filament formation controlled by a phosphatase to regulate morphogenesis and virulence.
... Interestingly, two Gal4 analogues, Rtg1 and Rtg3, have a great impact during both systemic infections and gut colonisation, although they are involved in the regulation of a broader range of cellular processes [68]. Moreover, carbohydrate metabolism is intimately linked to C. albicans morphogenesis, with nutrient starvation or serum presence being among the factors inducing the yeast-to-hypha transition [69,70]. Metabolic genes are regulated during hyphal growth, including Adh1, Pgk1, and Gpm1 [71]. ...
... Moreover, Efg1 stimulates fermentation and suppression of respiratory metabolism, demonstrating the importance of glycolytic metabolism in controlling virulence attributes [73]. This ability allows Candida species to switch between Moreover, carbohydrate metabolism is intimately linked to C. albicans morphogenesis, with nutrient starvation or serum presence being among the factors inducing the yeast-tohypha transition [69,70]. Metabolic genes are regulated during hyphal growth, including Adh1, Pgk1, and Gpm1 [71]. ...
Article
Full-text available
Microscopic fungi are widely present in the environment and, more importantly, are also an essential part of the human healthy mycobiota. However, many species can become pathogenic under certain circumstances, with Candida spp. being the most clinically relevant fungi. In recent years, the importance of metabolism and nutrient availability for fungi-host interactions have been highlighted. Upon activation, immune and other host cells reshape their metabolism to fulfil the energy-demanding process of generating an immune response. This includes macrophage upregulation of glucose uptake and processing via aerobic glycolysis. On the other side, Candida modulates its metabolic pathways to adapt to the usually hostile environment in the host, such as the lumen of phagolysosomes. Further understanding on metabolic interactions between host and fungal cells would potentially lead to novel/enhanced antifungal therapies to fight these infections. Therefore, this review paper focuses on how cellular metabolism, of both host cells and Candida, and the nutritional environment impact on the interplay between host and fungal cells.
... aureus Biofilms Several chemicals produced by both S. aureus and C. albicans can influence polymicrobial biofilm formation through cross-species signaling. One of the best-studied chemical signals that can alter both C. albicans and S. aureus physiology is farnesol (68). Farnesol is a quorum-sensing molecule derived from glycolytic products via the sterol pathway in C. albicans (68). ...
... One of the best-studied chemical signals that can alter both C. albicans and S. aureus physiology is farnesol (68). Farnesol is a quorum-sensing molecule derived from glycolytic products via the sterol pathway in C. albicans (68). Farnesol blocks the C. albicans morphological transition from yeast to hyphae under high cell density (69). ...
Article
Full-text available
Successful pathogens require metabolic flexibility to adapt to diverse host niches. The presence of co-infecting or commensal microorganisms at a given infection site can further influence the metabolic processes required for a pathogen to cause disease. The Gram-positive bacterium Staphylococcus aureus and the polymorphic fungus Candida albicans are microorganisms that asymptomatically colonize healthy individuals but can also cause superficial infections or severe invasive disease. Due to many shared host niches, S. aureus and C. albicans are frequently co-isolated from mixed fungal-bacterial infections. S. aureus and C. albicans co-infection alters microbial metabolism relative to infection with either organism alone. Metabolic changes during co-infection regulate virulence, such as enhancing toxin production in S. aureus or contributing to morphogenesis and cell wall remodeling in C. albicans. C. albicans and S. aureus also form polymicrobial biofilms, which have greater biomass and reduced susceptibility to antimicrobials relative to mono-microbial biofilms. The S. aureus and C. albicans metabolic programs induced during co-infection impact interactions with host immune cells, resulting in greater microbial survival and immune evasion. Conversely, innate immune cell sensing of S. aureus and C. albicans triggers metabolic changes in the host cells that result in an altered immune response to secondary infections. In this review article, we discuss the metabolic programs that govern host-pathogen interactions during S. aureus and C. albicans co-infection. Understanding C. albicans-S. aureus interactions may highlight more general principles of how polymicrobial interactions, particularly fungal-bacterial interactions, shape the outcome of infectious disease. We focus on how co-infection alters microbial metabolism to enhance virulence and how infection-induced changes to host cell metabolism can impact a secondary infection.
... The downregulation of the RAS1 gene in C. albicans biofilm in the presence of the tested antifungal agents, particularly cinnamon oil and SDS, implies that they might inhibit the expression of filament-inducing genes via an RAS1-mediated way (Ras1-cAMP-Efg1 and Cek1-Cph1p pathways). As a result, hyphal growth and biofilm formation are inhibited (Han et al., 2011). ...
Article
Full-text available
Little is known about the interactions among phagocytes and antifungal agents and the antifungal immunomodulatory activities on Candida species biofilms. Here, inhibition of C. albicans biofilms and the interactions among biofilms and phagocytes alone or in combination with essential oils, biological, and chemical agents, or fluconazole were investigated. Biofilm formation by a panel of 28 C. albicans clinical isolates from hospitalized patients, birds, and cattle was tested. The anti-biofilm activities of cinnamon and clove oils, sodium dodecyl sulfate (SDS), cetyltrimethylammonium bromide (CTAB), and Enterococcus faecalis cell-free supernatant (CFS) in comparison with fluconazole were investigated using crystal violet and XTT reduction assays, expression of hypha-specific and hyphal regulator genes, and scanning electron microscopy (SEM) analysis. Of the tested C. albicans isolates, 15 of 28 (53.6%) were biofilm producers. Cinnamon followed by E. faecalis–CFS, SDS, and CTAB was the most effective inhibitors of planktonic C. albicans and biofilms. Fluconazole was an ineffective inhibitor of C. albicans biofilms. Sessile minimal inhibitory concentration (SMIC50) of cinnamon, SDS, CTAB, and E. faecalis–CFS downregulated the hypha-specific and regulator genes, albeit to various extents, when compared with untreated biofilms (P < 0.001). SEM analysis revealed disruption and deformity of three-dimensional structures in cinnamon oil–treated biofilms. C. albicans sessile cells within biofilm were less susceptible to phagocytosis than planktonic cells. The additive effects of phagocytes and the tested antifungals enabled phagocytes to engulf C. albicans cells rapidly in cinnamon, E. faecalis–CFS, or SDS-treated biofilms. No differences in anti-Candida or anti-biofilm eradication activities were detected among the tested isolates. Our findings reinforce the substantial anti-biofilm activity of cinnamon oil, SDS, and E. faecalis–CFS and provide new avenues for the development of novel anti-biofilm immunotherapies or antifungals that could be used prior to or during the management of cases with biofilm-associated infections.
... The dimorphic shift of branching budding yeast on the 1st day to pseudohyphal growth on the 15th day was observed under phase contrast microscope, since it is evident that yeast-like and pseudohyphal morphologies can be achieved depending upon the kind of nitrogen and carbon source being used. Apart from this, CO 2 produced during ethanol formation by yeast might also induces the formation of filamentous morphology by activating hypha-specific genes [33]. The morphology of P. fermentans is regulated by the quorum sensing molecule depending upon the nitrogen source and its starvation [34]. ...
Article
Full-text available
Lignocellulosic biomass holds a potential to be used in the production of biofuels and bioelectricity, as an economic and eco-friendly substrate. The production of bioethanol and bioelectricity was evaluated in a microbial electrochemical reactor using wheat straw hydrolysate. Wood degrading white-rot fungi, Phlebiafloridensis, was used to prepare wheat straw hydrolysate. An efficient bioconversion of sugars present in wheat straw hydrolysate into ethanol and electricity has been demonstrated to achieve a cost-effective and net-zero emissions goal using co-cultures of yeasts. The fermentation was performed in a single vessel electrochemical bioreactor using Saccharomyces cerevisiae and Pichia fermentans. Both the yeasts were allowed to ferment WS hydrolysate up to 15 days as pure or co-culture. Co-culture of yeasts showed electrochemical response in terms of maximum power density (77.5 mW m⁻²) using WS hydrolysate. Maximum ethanol production of 8.7% (w/v) was observed on the 5th day. Thus, the results of this study validate the use of biological integrated approach like microbial electrochemical reactor to produce ethanol and electricity from wheat straw hydrolysate.
... The upregulated pathways were enriched in genes encoding cellular amino acid and small-molecule biosynthetic and metabolic processes (Supplementary Data 2). C. albicans metabolism plays a central role in biofilm formation and hyphal morphogenesis; 13 thus, metabolic changes may correlate with virulence suppression. Together, these data indicate that mucins across various mucosal surfaces downregulate virulence-associated gene expression and phenotypes, providing rich sources of bioactive molecules for regulating C. albicans. ...
Article
Full-text available
Mucins are large gel-forming polymers inside the mucus barrier that inhibit the yeast-to-hyphal transition of Candida albicans, a key virulence trait of this important human fungal pathogen. However, the molecular motifs in mucins that inhibit filamentation remain unclear despite their potential for therapeutic interventions. Here, we determined that mucins display an abundance of virulence-attenuating molecules in the form of mucin O-glycans. We isolated and cataloged >100 mucin O-glycans from three major mucosal surfaces and established that they suppress filamentation and related phenotypes relevant to infection, including surface adhesion, biofilm formation and cross-kingdom competition between C. albicans and the bacterium Pseudomonas aeruginosa. Using synthetic O-glycans, we identified three structures (core 1, core 1 + fucose and core 2 + galactose) that are sufficient to inhibit filamentation with potency comparable to the complex O-glycan pool. Overall, this work identifies mucin O-glycans as host molecules with untapped therapeutic potential to manage fungal pathogens.
... Candida infections (candidiasis) can be life threatening, particularly in individuals who are critically ill, (immunodeficiency syndrome, hematological malignancy) causing mortality rates of over 30-40% [2]. Adhesion to a surface, whether mammalian or synthetic, is the first step in its pathogenic phase followed by a morphological change from the yeast to hyphae phenotype (the virulent state) [3]. ...
Article
Fungi are considered "silent killers" due to the difficulty of, and delays in diagnosis of infections and lack of effective antifungals. This challenge is compounded by the fact that being eukaryotes, fungi share several similarities with human cellular targets, creating obstacles to drug discovery. Candida albicans, a ubiquitous microbe in the human body is well-known for its role as an opportunistic pathogen in immunosuppressed people. Significantly, C. albicans is resistant to all the three classes of antifungals that are currently clinically available. Over the past few years, a paradigm shift has been recommended in the management of C. albicans infections, wherein anti-virulence strategies are considered an alternative to the discovery of new antimycotics. Small molecules, with a molecular weight <900 Daltons, can easily permeate the cell membrane and modulate the signal transduction pathways to elicit desired virulence inhibitory actions against pathogens. This review dissects in-depth, the discoveries that have been made with small-molecule anti-virulence approaches to tackle C. albicans infections.
Chapter
Full-text available
There has been a tremendous enhancement in the occurrence of invasive fungal diseases. In immunocompromised persons, invasive fungal diseases are found correlated with high mortality and morbidity rates. Unfortunately, there are limited treatment strategies available against the increasing fungal drug resistance phenomenon associated with different human fungal pathogenic species. Moreover, the currently available antifungals are associated with severe issues including host toxicity, fungistatic property, and the development of fungal drug resistance in the concerned pathogens. There is an instant need for the identification, establishment, and advancement of novel treatment strategies for the eradication of increasing human fungal diseases. Drug combination therapy could be a novel successful therapeutic approach to improve the potency of the drug and alleviate the advancement of the phenomenon of drug resistance. In this chapter, we will be providing a detailed account of the importance of a drug combinatorial approach for the cure of increasing human fungal infections.
Article
Full-text available
The present study was deliberately focused to explore the antivirulence efficacy of a plant allelochemical—catechol against Candida albicans, and attempts were made to elucidate the underlying mechanisms as well. Catechol at its sub-MIC concentrations (2–256 μg/mL) exhibited a dose dependent biofilm as well as hyphal inhibitory efficacies, which were ascertained through both light and fluorescence microscopic analyses. Further, sub-MICs of catechol displayed remarkable antivirulence efficacy, as it substantially inhibited C. albicans’ virulence enzymes i.e. secreted hydrolases. Notably, FTIR analysis divulged the potency of catechol in effective loosening of C. albicans’ exopolymeric matrix, which was further reinforced using EPS quantification assay. Although, catechol at BIC (256 μg/mL) did not disrupt the mature biofilms of C. albicans, their initial adherence was significantly impeded by reducing their hydrophobic nature. Besides, FTIR analysis also unveiled the ability of catechol in enhancing the production of farnesol—a metabolite of C. albicans, whose accumulation naturally blocks yeast-hyphal transition. The qPCR data showed significant down-regulation of candidate genes viz., RAS1, HWP1 and ALS3 which are the key targets of Ras-cAMP-PKA pathway -the pathway that contribute for C. albicans’ pathogenesis. Interestingly, the up-regulation of TUP1 (a gene responsible for farnesol-mediated hyphal inhibition) during catechol exposure strengthen the speculation of catechol triggered farnesol-mediated hyphal inhibition. Furthermore, catechol profusely enhanced the fungicidal efficacy of certain known antifungal agent’s viz., azoles (ketoconazole and miconazole) and polyenes (amphotericin-B and nystatin).
Article
Full-text available
Background: Farnesol is a sesquiterpene alcohol produced by many organisms, and also found in several essential oils. Its role as a quorum sensing molecule and as a virulence factor of Candida albicans has been well described. Studies revealed that farnesol affect the growth of a number of bacteria and fungi, pointing to a potential role as an antimicrobial agent.
Article
Full-text available
The Candida albicans INT1 gene is important for hyphal morphogenesis, adherence, and virulence (C. Gale, C. Bendel, M. McClellan, M. Hauser, J. M. Becker, J. Berman, and M. Hostetter, Science 279:1355–1358, 1998). The ability to switch between yeast and hyphal morphologies is an important virulence factor in this fungal pathogen. When INT1 is expressed in Saccharomyces cerevisiae, cells grow with a filamentous morphology that we exploited to gain insights into how C. albicans regulates hyphal growth. In S. cerevisiae, INT1-induced filamentous growth was affected by a small subset of actin mutations and a limited set of actin-interacting proteins including Sla2p, anS. cerevisiae protein with similarity in its C terminus to mouse talin. Interestingly, while SLA2 was required forINT1-induced filamentous growth, it was not required for polarized growth in response to several other conditions, suggesting that Sla2p is not required for polarized growth per se. The morphogenesis checkpoint, mediated by Swe1p, contributes toINT1-induced filamentous growth; however, epistasis analysis suggests that Sla2p and Swe1p contribute toINT1-induced filamentous growth through independent pathways. The C. albicans SLA2 homolog (CaSLA2) complements S. cerevisiae sla2Δ mutants for growth at 37°C and INT1-induced filamentous growth. Furthermore, in a C. albicans Casla2/Casla2 strain, hyphal growth did not occur in response to either nutrient deprivation or to potent stimuli, such as mammalian serum. Thus, through analysis ofINT1-induced filamentous growth in S. cerevisiae, we have identified a C. albicans gene,SLA2, that is required for hyphal growth in C. albicans.
Article
The dimorphic fungus Candida albicans produces extracellular farnesol (3,7, 11-trimethyl-2,6,10-dodecatriene- 1-ol) which acts as a quorum-sensing molecule (QSM) to suppress filamentation. Of four possible geometric isomers of farnesol, only the E,E isomer possesses QSM activity. We tested 40 natural and synthetic analogs of farnesol for their activity in an N-acetylglucosamine-induced differentiation assay for germ tube formation (GTF). Modified structural features include the head group, chain length, presence or absence of the three double bonds, substitution of a backbone carbon by S, O, N, and Se heteroatoms, presence or absence of a 3-methyl branch, and the bulkiness of the hydrophobic tail. Of the 40 compounds, 22 showed QSM activity by their ability to reduce GTF by 50%. However, even the most active of the analogs tested had only 7.3% of the activity of E,E-farnesol. Structure-activity relationships were examined in terms of the likely presence in C. albicans of a farnesol binding receptor protein. Includes supplemental material.
Article
Phosphoinositides are important lipid signalling molecules in eukaryotic cells. Phosphatidylinositol-4-phosphate 5-kinase (P14P5K) catalyses the production of phosphatidylinositol 4,5-bisphosphate (PIP2), which stimulates phospholipase D1 (PLD1) activity in mammalian and yeast cells. PLD1 catalyses the formation of phosphatidic acid (PA), which has been shown to activate P14P5Ks in mammalian and Saccharomyces cerevisiae cells. In the present study, P14P5K activity in the opportunistic pathogen Candida albicans was identified. A gene with significant sequence homology to the S. cerevisiae P14P5K was cloned and designated MSS4. This gene was demonstrated to encode a functional P14PSK by expression in S. cerevisiae. This enzyme was found to be membrane-associated and was stimulated by PA. Within the first 20 min after induction of polarized hyphal growth induced by a shift to elevated temperature, P14PSK activity increased 2-5-fold. This stimulation was not observed when hyphae were induced by a combination of elevated temperature and serum. A lack of PLD1 activity resulted in the loss of induction of P14PSK activity during the morphogenetic switch. Furthermore, the addition of propranolol attenuated the stimulation of P14PSK activity during morphogenesis. These results suggest that PA derived from PLD1 activity stimulates C. albicans P14P5K during the switch to the hyphal form under some conditions.
Article
Background: Candidiasis associated with indwelling medical devices is especially problematic since they can act as substrates for biofilm growth which are highly resistant to antifungal drugs. Farnesol is a quorum-sensing molecule that inhibits filamentation and biofilm formation in Candida albicans. Since in recent years Candida tropicalis have been rep